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1. SUMMARY 
Tip60 is a histone acetyl transferase (HAT) and a cofactor of transcription, but also an 
interaction partner of the Mdm2 oncoprotein. The functional consequences of this 
interaction are only partially understood and were further explored in this study. We found 
that Tip60 expression leads to an increase of Mdm2 and p53 protein levels, which is due 
to elevated protein half-lifes of these proteins. To explore the underlying mechanisms, the 
impact of Tip60 on the Mdm2-mediated ubiquitination of p53 was studied. However, we 
found that Tip60 expression does not affect p53-ubiquitination by Mdm2. Strikingly, Tip60 
is capable of selectively inhibiting the Mdm2-mediated conjugation of the neural precursor 
cell expressed developmentally downregulated 8 (Nedd8) to p53, which had been shown 
to reduce its transcriptional activity. In contrast, the known Mdm2 antagonist p14arf 
preferentially blocked Ubiquitin conjugation by Mdm2. To identify underlying mechanisms, 
we studied the intracellular localization of Tip60 and Mdm2. Both proteins relocalized each 
other to the PML nuclear bodies, but a similar localization pattern was observed even in 
the absence of PML. Analysis of Tip60 deletion mutants revealed a stringent correlation 
between relocalization with Mdm2 and reduced neddylation of p53 and Mdm2. For both 
activities, the MYST domain but not the HAT domain of Tip60 was required. We propose 
that Tip60 can act as a selective antagonist to Mdm2-mediated neddylation. Hence, the 
two different E3-Ligase activities of Mdm2 can be regulated individually.  
Furthermore, the effect of Tip60 on the transcriptional activity of p53 was investigated. 
Surprisingly, Tip60 overexpression did not result in a stimulation of p53 transcriptional 
activity, whereas the overexpression of the known Mdm2 antagonist p14arf did so. Studies 
of Tip60 knockdown showed that reduced Tip60 expression only mildly affects the p53-
dependent transactivation of its target gene promoters under non-stress conditions.  
Therefore, we investigated the role of Tip60 after ultraviolet (UV) irradiation. Immunoblot 
analysis after siRNA-mediated knockdown of the HTATIP gene (which encodes Tip60) 
expression showed that the cleavage of the poly(ADP-ribose) polymerase (PARP) upon 
UV irradiation was reduced, suggesting an impaired apoptotic response. However, the 
removal of p53 did not affect PARP cleavage, arguing that Tip60 enables UV induced 
apoptosis independently of p53. Instead, Tip60 knockdown led to reduced phosphorylation 
of histone 2AX (H2AX) and jun-N-terminal kinase (JNK), suggesting a role of Tip60 in the 
immediate early response to UV light exposure through JNK. 
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In this work, two additional roles of Tip60 have been unveiled that potentially contribute to 
tumor suppression. First, Tip60 can inhibit the Mdm2-mediated conjugation of the Nedd8 
protein to p53, thereby possibly releaving it from transcriptional inhibition by Mdm2. 
Moreover, Tip60 apparently is required for the proper activation of the UV-induced JNK-
signaling pathway, thereby ensuring an efficient response to DNA damage and apoptosis 
induction. 
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1.1 ZUSAMMENFASSUNG 
Das Tip60 Protein ist eine Histonazetyltransferase (HAT) und ein 
Transkriptionskofaktor, der zugleich auch mit dem Mdm2 Onkoprotein interagiert. Die 
funktionellen Konsequenzen dieser Interaktion sind allerdings nur teilweise bekannt 
und wurden deshalb in dieser Arbeit näher erforscht. Die Untersuchungen ergaben, 
dass die Überexpression von Tip60 zu einem Anstieg der Proteinmengen von p53 
und Mdm2 führt, was auf eine erhöhte Stabilität dieser Proteine zurückzuführen ist. 
Allerdings resultierte die Expression von Tip60 nicht in einer Inhibition der Mdm2-
vermittelten p53-Ubiquitinierung. Vielmehr reduzierte Tip60 die Mdm2-vermittelte 
Konjugation des Nedd8 (neural precursor cell expressed developmentally 
downregulated 8)-Proteins an p53, dem eine Transkriptions-reprimierende Wirkung 
zugeschrieben wird. Im Gegensatz hierzu führte die Expression des bekannten 
Mdm2-Regulators p14arf hauptsächlich zu einer Inhibition der p53-Ubiquitinierung. 
Um die zugrundeliegenden Mechanismen aufzuklären, wurde die intrazelluläre 
Lokalisation von Tip60 und Mdm2 untersucht. Beide Proteine relokalisierten sich 
gegenseitig und assoziierten mit den Promyelozytischen nukleären Domänen; jedoch 
wurde ein ähnliches Kolokalisationsmuster auch in Abwesenheit von PML 
beobachtet. Die Analyse von Tip60 Deletionsmutanten zeigte eine stringente 
Korrelation zwischen der Relokalisation von Mdm2 und der Inhibition der p53- und 
Mdm2-Neddylierung. Für beide Aktivitäten war die MYST-Domäne von Tip60, nicht 
aber dessen HAT-Domäne notwendig. Wir folgern, dass Tip60 als ein selektiver 
Antagonist der Mdm2-vermittelten Neddylierung fungieren kann. Die zwei E3-Ligase 
Aktivitäten von Mdm2 können also individuell reguliert werden.  
Weiterhin wurde der Einfluss von Tip60 auf die transkriptionelle Aktivität von p53 
untersucht. Erstaunlicherweise konnte Tip60, im Gegensatz zu p14arf, den 
reprimierenden Einfluss von Mdm2 nicht abschwächen. Die Suppression der Tip60-
Genexpression durch RNA-Interferenz zeigte nur einen schwachen inhibitorischen 
Effekt auf die transaktivierende Funktion von p53.  
Aus diesem Grund wurde die Rolle von Tip60 nach ultravioletter Strahlung (UV) 
untersucht. Die Analyse der Proteinexpression nach UV Bestrahlung zeigte, dass die 
Spaltung der Poly(ADP-Ribose) Polymerase (PARP) nach Suppression des HTATIP 
Gens (welches Tip60 kodiert) reduziert ist, was auf eine Inhibition der apoptotischen 
Antwort hinweist. Die Suppression der p53-Expression hingegen, beeinflußte die 
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PARP-Spaltung nicht, was darauf hindeutet, dass Tip60 unabhängig von p53 die UV-
induzierte Apoptose fördert. Weiterhin wurde eine verringerte Phosphorylierung des 
Histon 2AX und der jun-N-terminalen Kinase (JNK) beobachtet, was auf eine frühe 
Inhibition der zellulären Antwort auf DNA-Schäden hindeutet. 
In dieser Arbeit wurden zwei neue Funktionen von Tip60 identifiziert, die potentiell 
zur Tumorsuppression beitragen. Einerseits inhibiert Tip60 die Mdm2-vermittelte 
p53-Neddylierung und trägt damit evtl. zur Aktivierung von p53 bei. Weiterhin wird 
Tip60 anscheinend für die Aktivierung des UV-induzierten JNK-Signalwegs benötigt 
und trägt somit zu einer effizienten Antwort auf DNA-Schäden durch Aktivierung von 
Apoptose bei.  
Introduction                                                                                                                 5 
2 INTRODUCTION 
2.1 The tumor suppressor p53 
The tumor suppressor p53 is encoded by a gene that is frequently mutated in human 
cancer. About 50% of all human tumors have no p53 or carry mutations in the TP53 
gene that lead to the inactivation of the p53 protein (Hollstein et al., 1994). The rest 
of the tumors exhibit mutations in other genes that finally result in a functional 
inactivation of p53. The p53 protein is a nuclear protein and acts mainly as a 
transcription factor. Upon activation, p53 forms first dimers that then further associate 
to tetramers. The p53 tetramer then binds to conserved p53 elements, inverted 
sequences, in the promoters of its target genes (Lu and Levine, 1995). After the 
recruitment of further cofators such as histone acetyl transferases, the transcription 
of its target genes begins. Under certain circumstances, p53 can act independently of 
transcriptional activation by stimulating the induction of apoptsis directly at the 
mitochondria (Mihara et al., 2003).  
p53 is activated upon exposure of the cell to various stress stimuli including DNA 
damage, activation of oncogenes like Ras or hypoxia (reviewed in Vousden and Lu, 
2002). It is also called the “guardian of the genome”, because it is required for 
maintaining the genomic integrity of a cell. p53 integrates various stress and survival 
signals to decide whether the damage of a cell can be repaired or whether the 
survival of the cell would be detrimental for the whole organism. In the latter case, 
p53 activates the transcription of apoptosis-related genes whose effects finally lead 
to the death of the cell, thereby preventing the development of a potential tumor cell. 
The outcome of p53 activation can be cell cycle arrest, senecence or apoptosis.  
The p53 protein exerts its function as a tumor suppressor by activating basically two 
groups of target genes: genes involved in cell cycle regulation like the inhibitor of 
cyclin-dependent kinases (CDK) p21wafcip or the 14-3-3sigma protein which is 
involved in regulating the G2/M transition (el-Deiry et al., 1994; el-Deiry et al., 1993; 
Hermeking et al., 1997). The p21 protein binds to the CDK-cyclin complexes like 
CDK2-cyclin E and inhibits their kinase activity towards their targets, the proteins of 
the retinoblastoma family (Obaya and Sedivy, 2002). The second group of p53 target 
genes, like Noxa, Puma or Bax, is involved in the induction of programmed cell death 
or apoptosis. Bax for example stimulates the cytochrome c-release from the 
mitochondria, resulting in the activation of a group of specific proteases, called 
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caspases, which among others, leads to cleavage of the Poly(ADP-Ribose) 
polymerase (PARP), DNA fragmentation and finally cell death (reviewed in Green 
and Evan, 2002).  
p53 exhibits a highly conserved domain structure, its C-terminus contains the 
oligomerisation domain. The DNA binding of p53 is mediated by the central DNA 
binding domain and the N-terminal domain, the so-called transactivation domain, is 
required for transcriptional activation, by the recruitment of transcription cofactors.  
The p53 protein must be regulated very tightly to avoid its activation under non-stress 
conditions, which would be harmful for the cell. This regulation is mainly 
accomplished on the posttranslational level. Under non-stress conditions, p53 is 
present only at very low levels. However, upon the induction of DNA damage, p53 
becomes phosphorylated by several DNA-damage induced kinases like ATM or ATR, 
leading to its stabilisation and subsequent activation (reviewed in Niida and 
Nakanishi, 2006). The protein levels of p53 are regulated by ubiquitination, which is 
mainly mediated by the oncoprotein Mdm2. Ubiquitinated p53 is exported from the 
nucleus to the cytoplasm and subsequently degraded by the 26S proteasome (Figure 
2.1 A). Apart from Mdm2, the E3-Ligases hPirh2 and COP1 have been described 
recently to antagonise p53 by ubiquitination (reviewed in Brooks and Gu, 2006).  
 
2.2 The Ubiquitin ligase Mdm2 
Originally, the MDM2-gene was isolated from the transformed mouse cell line 3T3DM 
(Cahilly-Snyder et al., 1987). The Mdm2 protein is a nuclear phospho protein of 
about 90 kDa that is encoded by the human homolog of the mouse double minute 
gene. In several sarcomas, the MDM2-gene was found to be amplified, hinting at a 
potential contribution of Mdm2 to tumorigenesis (Oliner et al., 1992). 
Mdm2 is a RING-finger protein that catalyses the addition of ubiquitin moieties to its 
substrate p53 by virtue of its E3 Ubiquitin ligase activity (Figure 2.1 A). The 
ubiquitination of p53 by Mdm2 predominantly occurs on six lysines, located at the 
extreme C-terminus of p53, but recently also lysine residues in the central domain of 
p53 have ben described as ubiquitination targets (Chan et al., 2006).  
Some reports demonstrated that Mdm2 mainly functions to monoubiquitinate p53, 
thereby stimulating its nuclear export (Figure 2.1 B) where it is polyubiquitinated and 
subsequently degraded. The histone acetyl transferase p300 has recently been 
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implicated in the polyubiquitination of monoubiquitinated p53, thereby acting as an 
E4-Ligase (Grossman et al., 2003; Michael and Oren, 2003).  
Moreover, Mdm2 binds to p53 in the vicinity of its transactivation domain, thereby 
inhibiting its interaction with transcription cofactors (Momand et al., 1992; Oliner, 
1993). The Mdm2 protein binds to p53 via its N-terminal domain (Chen et al., 1993), 
while the central domain contains binding sites for proteins like TBP, p14arf, p300 
and pRb as well as signal sequences that play a role in the shuttling of Mdm2 
between the nucleus and the cytoplasm. The C-terminal RING-finger domain 
mediates the ubiquitination of p53 (for a review, see Meek and Knippschild, 2003). 
Apart from ubiquitinating p53, Mdm2 is also capable of ubiquitinating itself, a process  
 
 
Figure 2.1  Different modification states of p53 and Mdm2 
a) In unstressed cells a small amount of p53 is present in the nucleus, so that the level of 
transcriptional activity is low. This is due to different modification strategies: at high expression levels 
of Mdm2, p53 is polyubiquitinated (Ub) and degraded. Proteasomes both present in the nucleus and 
the cytosol are capable of degrading p53. b) If Mdm2 is present at low levels it can mono-ubiquitinate 
p53, thereby leading to the export of p53. In the cytosol, p53 monoubiquitination can be extended to 
polyubiquitination resulting in its degradation. It can also be deubiquitinated and shuttle back into the 
nucleus c) DNA damage activates several kinases that phosphorylate (P) p53 at its interaction surface 
with Mdm2. d) Mdm2 was shown to mediate its conjugation with Nedd8 (N), resulting in decreased 
transcriptional activity. Figure modified from Hoeller et al., 2006. 
Unstressed cells 
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called auto-ubiquitination. Like ubiquitinated p53, Mdm2 is then degraded by the 
proteasome.  
Recent reports have shown that Mdm2 not only acts as an E3-Ligase for Ubiquitin, 
but that it also mediates linkage of the neural cellular precursor developmentally 
downregulated 8 (Nedd8) to p53. Nedd8 is homologous to ubiquitin and exhibits an 
amino acid identity of 57% to ubquitin, thereby being its closest relative (reviewed in 
Watson and Irwin, 2006). Nedd8 has been implicated in cell cycle regulation and 
belongs to the family of ubiquitin-like modifiers. The conjugation of Nedd8 to its 
targets requires the E1 activating enzyme which consists of a heterodimer of the 
amyloid precursor binding protein 1 (APP-BP1) and the Uba3 protein, the E2-
conjugating enzyme hUbc12 and a specific E3 ligase (Figure 2.2). While 
ubiquitination of p53 targets it for the proteasomal degradation, neddylation of p53 
compromises its transcriptional activity. Neddylation occurs on at least three C-
terminal lysine residues of p53 that are also subject to ubiquitination by Mdm2. The 
neddylating activity of Mdm2 is dependent on the same cysteine residue (C464) in 
the RING-finger domain as its ubiquitination activity. In analogy to the auto-
ubiquitination of Mdm2, its auto-neddylation has been described, which in turn results 
in a mitigation of its repressive effect on p53 (Xirodimas et al., 2004).  
 
Figure 2.2: General overview of the ubiquitin and UBL protein conjugation pathways 
(1) Ubiquitin, SUMO and Nedd8 are synthesised as precursors that are processed at a conserved C-
terminal glycine residue by the hydrolase activity of deubiquitinating, desumoylating and deneddylating 
enzymes, generating an exposed Gly-Gly motif that serves as the attachment site to target substrates. 
(2) The exposed C-terminal glycine of ubiquitin/SUMO/Nedd8 is adenylated by an activating (E1) 
enzyme in an ATP dependent manner and is transferred to an active E1 cysteinyl side chain through a 
thiol ester linkage. (3) Activated ubiquitin/SUMO/Nedd8 is subsequently transferred to a conjugating 
(E2) enzyme, forming another thiol ester linkage. (4) A ligase (E3) transfers ubiquitin/SUMO/Nedd8 to 
the ε-amino group of a substrate lysyl residue of target substrates, resulting in the formation of an 
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2.2.1 Regulators of Mdm2 
The activity of Mdm2 is regulated by its own abundance and also by interaction with 
other proteins. The levels of Mdm2 are regulated on the mRNA level and on the 
protein level. As one of the p53 target genes, Mdm2 is induced upon p53 activation. 
Newly synthesized Mdm2 itself binds p53 and targets it for degradation, thereby 
establishing a negative feedback loop (Wu et al., 1993). On the other hand, Mdm2 is 
regulated in its protein stability. Several kinases that phosphorylate p53, also exhibit 
this activity towards Mdm2. For instance, Mdm2 is phosphorylated at serine 395 by 
the ATM-kinase (ataxia telangiectasia-mutated) upon DNA damage. This results in 
the inhibition of p53 export to the cytoplasm and its subsequent degradation (Maya et 
al., 2001). Moreover, Mdm2 is acetylated by the CBP-complex, compromising the 
capability of Mdm2 to target p53 for degradation (Wang et al., 2004). Phosphorylation 
of Mdm2 at serine 166 and 186 by the Akt kinase, however, leads to a block of the 
Mdm2-p14arf interaction, thereby stimulating the degradation of p53 (Gottlieb et al., 
2002). 
p14arf is a small, nucleolar protein that is encoded by the INK4A/ARF locus. By 
directly interacting with Mdm2, p14arf is capable of inhibiting the Mdm2-mediated 
p53-degradation (Pomerantz et al., 1998). Binding of p14arf to Mdm2 results in a 
conformational change of Mdm2, thereby revealing a previously hidden signal 
sequence. This leads to the sequestration of Mdm2 to the nucleolus, freeing p53 
from the impact of Mdm2 (Tao and Levine, 1999; Weber et al., 2000).  
This mechanism leads to the disruption of the negative feedback loop, allowing p53 
to activate its target genes (Weber et al., 1999). 
Moreover, ribosomal proteins have been implicated in the regulation of Mdm2. Like 
p14arf, the ribosomal L11 protein binds Mdm2 and inactivates it, resulting in 
stabilization of p53 levels (Lohrum et al., 2003). Recently it was reported that L11 
differentilally regulates the stability of Mdm2 and p53. Ubiquitinated Mdm2 
accumulates due to an inhibition of a subsequent degradation step (Dai et al., 2006). 
Furthermore, the ribosomal proteins L5 and L23 interfere with the Mdm2 function and 
are found in complex with Mdm2. These proteins are capable of inducing a p53-
dependent cell cycle arrest (Dai and Lu, 2004; Jin et al., 2004). 
The Mdm2 homolog MdmX has also been described to regulate Mdm2 by inhibiting 
the Mdm2-mediated p53 export and degradation (Jackson and Berberich, 2000). 
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The PML protein is another regulator of Mdm2. It is a nuclear RING-finger protein 
that, together with several other proteins, forms nuclear structures that are called 
PML nuclear bodies (PML NBs) or PML oncogenic domains (PODs). Although their 
direct role in nuclear activity is unclear, PML NBs are implicated in the regulation of 
transcription, apoptosis, tumor suppression and the anti-viral response (reviewed in 
Dellaire and Bazett-Jones, 2004). An emerging view is that they represent sites 
where multi-subunit complexes form and where posttranslational modification of 
regulatory factors, such as p53, occurs in response to cellular stress. Following DNA 
damage, several repair factors transit through PML NBs in a temporally regulated 
manner implicating these bodies in DNA repair. PML has been shown to interact with 
p53 and Mdm2, resulting in inhibition of Mdm2-mediated p53-degradation. Moreover, 
PML neutralizes the inhibitory effects of Mdm2 by prolonging the stress-induced 
phosphorylation of p53 on serine 20, a site of the checkpoint kinase 2 (Chk2). PML 
recruits Chk2 and p53 into the PML nuclear bodies and enhances the p53/Chk2 
interaction (Louria-Hayon et al., 2003). Another mechanism, by which PML protects 
p53, is the sequestration of Mdm2 to the nucleolus, thereby precluding it from p53 
(Bernardi et al., 2004).  
 
2.3 The histone acetyl transferase Tip60 
The Tip60 protein was originally identified as an interacting protein of the HIV-tat 
protein (Kamine et al., 1996). It is a nuclear protein of 60 kDa size that is present in 
three different splice variants (reviewed in Sapountzi et al., 2006). Tip60 contains 
several conserved domains, the N-terminally located chromo-domain is required for 
the recognition of methylated histone tails. In the center/N-terminus of the protein the 
MYST domain is found. It defines the membership of Tip60 to the family of the MYST 
histone acetyl transferases and contains the catalytical HAT domain as well as a 
zinc-finger motif which is essential for the acetyltransferase activity and is required 
for protein-protein interactions (Barron et al., 2005; Hlubek et al., 2001; Nordentoft 
and Jorgensen, 2003; Xiao et al., 2003) (Figure 2.3). The MYST domain is the region 
of homology remarkably well conserved and common among all family members.  
The exon 5 is deleted in one of the splice variants, called PLIP (cPLA2 interacting 
protein). PLIP interacts with cPLA2, a cytosolic phosphatase that is activated by 
calcium ions and that is transported to the nuclear membrane and has been 
implicated in the apoptotic response (Sheridan et al., 2001).  
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Depending on the cellular process in which it participates, Tip60 forms distinct 
transient complexes with the appropriate binding partners. However, the majority of 
cellular Tip60 exists in a stable nuclear multiprotein complex, the evolutionary 
conserved NuA4 complex, that consists of at least 18 subunits and performs most 
transcriptional and DNA damage-related Tip60 functions. Central to the Tip60 stable 
complex is the scaffold protein TRRAP (transformation/ transcription domain 
associated protein) (Ikura et al., 2000), which is present in other acetyltransferase 
complexes, e.g. PCAF (p300/CBP associated factor complex). Moreover, the NuA4-
Tip60 complex contains helicases as the RuvB-like proteins Tip48 and Tip49 
(reviewed in Sapountzi et al., 2006). The NuA4 complex acetylates nucleosomal 
histones H4 and H2A by the addition of an acetyl group to the ε-amino group of 
specific lysines. Thereby it contributes to a loosening of the chromatin structure and 
facilitates the binding of further transcripton factors to the promoter, finally leading to 
the recruitment of the RNA polymerase II and activation of gene transcription 








Figure 2.3 : Primary structure of Tip60 
The figure shows the so far known domains of Tip60. In between the chromatin organising domain (aa 
28-78) and the exon 5 (aa 96-147) a cyclinB/Cdc2 recognition site is found, with serine 90 as an 
acceptor residue.The MYST domain (aa 262-390) contains two more domains, a zinc-finger motif (aa 
262-283) as well as the catalytic acetyl transferase domain (aa 367-390) 
 
Recent work in different experimental systems implicated that Tip60 plays a role on 
several levels of the DNA damage response and repair. For example, it was 
observed that the acetylation of ATM by Tip60 is required for its activation by 
stimulating its autophosphorylation, which results in the ATM dimer dissociation (Sun 
et al., 2005). A major substrate of ATM is the histone variant H2AX, which becomes 
phosphorylated in nucleosomes adjacent to the double strand break (DSB) (reviewed 










28 78 96 147 262 390 
283 367 
1 513 
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drosophila homolog of Tip60 is needed for the exchange of histones at sites of DNA 
damage (Kusch et al., 2004).  
Also, it was found that the knockdown of Tip60 compromises the cellular response to 
UV irradiation (Tyteca et al., 2006). Moreover, the overexpression of a HAT-deficient 
Tip60 mutant led to inhibition of apoptosis after UV irradiation (Ikura et al., 2000).  
The functions of Tip60 in DNA damage response and transcriptional control are likely 
to contribute together and in a complex manner to the cellular response to genotoxic 
stress.  
Apart from playing a role in tumor suppression, Tip60 has also been implicated in 
tumor promotion. This is in part due to its role as an activator of E2F-induced 
transcription, which is needed for cell cycle progression (Taubert et al., 2004). The 
transcription factor Myc has also been shown to rely on the HAT-activity of Tip60. In 
this case, the recruitment is mediated by the TRRAP protein (Frank et al., 2003). 
Furthermore, Tip60 was described to acetylate the tumor suppressor pRb 
(retinoblastoma protein), resulting in its accelerated degradation (Leduc et al., 2006).  
 
2.3.1 The role of Tip60 in the p53 pathway 
Experiments based on RNA interference showed that reduced Tip60 levels bypassed 
p53-induced cellcycle arrest in human cells, suggesting that Tip60 is rate limiting for 
the biological activity of p53 (Berns et al., 2004; Legube et al., 2004; Tyteca et al., 
2006). In addition to preventing p53-dependent cell cycle arrest, Tip60 knockdown 
also prevented induction of the CDK inhibitor p21 (Berns et al., 2004; Legube et al., 
2004; Tyteca et al., 2006). Furthermore, overexpression of Tip60 together with p53 
enhanced p21 expression levels in 293T cells (Doyon et al., 2004). Given the fact 
that Tip60 is a bona fide histone acetyl transferase, these findings suggest a role of 
Tip60 as a transcriptional coactivator of p53. In fact, p53 induced histone H4 
acetylation on its target promotors but it is unclear whether this is mediated by Tip60 
(Kaeser and Iggo, 2004).  
However, Tip60 was also found to bind the p53-antagonist Mdm2, which had initially 
been reported to result in the ubiquitination and subsequent degradation of Tip60. 
This Mdm2-mediated degradation was abolished after UV-irradiation, revealing a co-
reguation of Tip60 and p53 upon DNA damage. Strikingly, this interaction did not only 
affect the Tip60 protein but in turn also led to inhibition of the Mdm2-dependent p53 
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degradation (Legube et al., 2004). Interestingly, Tip60 is not capable of inhibiting the 
Mdm2-mediated ubiquitination of p53.  
Taking into account that Mdm2 not only affects p53 abundance by targeting it for 
degradation by ubiquitination, but also its transcriptional activity by Neddylation, this 
prompted us to ask whether Tip60 might additionally interfere with this activity.  
In this work it should be investigated how Tip60 contributes to tumor suppression 
with the focus on the Mdm2-p53-pathway.   
 
2.4 The cellular response to UV irradiation 
UV light is electromagnetic radiation emitted from the sun (or an artificial source) and 
it is divided to three areas according to its wavelength: UV-A 315-380 nmn, UVB 280 
– 315 nm and UV-C 190-280 nm. The ozone layer absorbs solar UV-C and most of 
UV-B, and it is estimated that 1-10% of UV radiation on the surface of Earth is UV-B 
and over 90% UV-A. However, the proportion of shorter wavelengths is increasing 
due to stratopheric ozone depletion (Lloyd, 1993).  
UV irradiation damages the cell mainly by directly affecting the DNA and by the 
production of reactive oxygen species that then damage other cellular components. 
The most apparent types of UV-radiation induced DNA damage are cyclobutane-type 
pyrimidine dimers and (6-4)-photoproducts, which crosslink adjacent DNA bases 
(Ravant et al., 2001). The DNA damage induced by UV radiation triggers several 
signaling cascades to provoke a cellular response.  
Cellular response to UV radiation depends on the cell type, the wavelength, and the 
dose of UV radiation inflicted on the cells. Several studies have used UV-C radiation. 
Although it is not a physiological wavelength, it serves as a good model to study the 
UV induced bulky DNA lesions.  
After the DNA damage is recognized, the primary cellular DNA damage sensors are 
activated; these include the phosphoinoside-3-kinase (PI-3-kinase)-related proteins 
ATM and ataxia telangiactasia related (ATR), which have overlapping functions. ATM 
is essential for IR (ionizing radiation)-induced and ATR for UV-induced 
phosphorylation of several G1/S checkpoint kinases. The checkpoint kinases Chk1 
and Chk2 phosphorylate among other subtrates also p53, leading to its activation 
and subsequent cell cycle arrest by induction of p21 (reviewed in Latonen and Laiho, 
2005) and (see chapter 2.1).  
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Low doses of UV irradiation induce a transient cell cycle arrest with the transient 
induction of p53, whereas high doses of UV radiation induce apoptosis correlating 
with a slower, but more sustained and, perhaps, more pronounced induction of p53. 
The apoptotic p53 UV response involves the upregulation of apoptotic targets like 
Bax or Noxa (reviewed in Latonen and Laiho, 2005).  
The repair of UV-induced DNA lesions is launched immediately after a UV insult. The 
helix-distorting DNA adducts induced by UV irradiation are repaired by nucleotide 
excision repair (NER) in mammalian cells (de Laat et al., 1999). 
One of the proteins that is involved in the signal transduction of DNA damage signals 
is the p53BP1 protein, which functions as a sensor of DNA double strand breaks 
(reviewed in Adams and Carpenter, 2006).   
Furthermore, UV radiation results in activation (phosphorylation) of the MAP kinases 
(mitogen activated protein kinases), the jun-N-terminal kinase (JNK) and the p38 
kinase. The induction of MAP kinases depends on the dose, time, and wavelength of 
UV radiation, subsequently regulating cell growth control, survival, chromatin 
remodeling, and apoptosis (Bode and Dong, 2003). The JNK protein phosphorylates 
among other factors the transcription factor c-jun, leading to its activation (Derijard et 
al., 1994; Hibi et al., 1993).  
As sensors of DNA damage and cellular stress the PML nuclear bodies also play a 
role in the response to UV irradiation. UV radiation causes rapid rearrangements of 
PML NBs and promotes PML-p53 and PML-Mdm2 complex formation, coincinding 
with p53 stabilization (Kurki et al., 2003). In addition, UV radiation leads to an 
increase in both PML protein levels and in the number of PML NBs (de Stanchina et 
al., 2004; Xu et al., 2003). Moreover, knockdown of PML sensitizes cells to UV-
induced apoptosis.  
One of the proteins that is associated with the PML NBs and interacts with the PML 
protein is the death domain associated protein (Daxx). Daxx was originally cloned as 
a CD95 (FAS)-interacting protein and modulator of FAS-induced cell death (reviewed 
in Salomoni and Khelifi, 2006). It has been implicated in the induction of UV-induced 
apoptosis by JNK (Khelifi et al., 2005; Wu et al., 2002).  
UV irradiation moreover leads to a stabilization of Tip60 by interfering with the Mdm2-
mediated degradation of Tip60 (Legube et al., 2002) (see chapter 2.3).  
Following UV irradiation, knockdown of Tip60 compromises the ability of p53 to bind 
to its target sequences on the p21 promotor (Tyteca et al., 2006).  
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2.5 Questions to be addressed in this work 
The following questions should be addressed in this work: 
• Which impact does Tip60 have on the protein levels of Mdm2 and p53? 
• Does Tip60 interfere with the E3 ligase activities of Mdm2, e.g. ubiquitination 
and neddylation actvities? 
• Which domains on Tip60 are required for the regulation of Mdm2 and p53? 
• Is the direct association of Tip60 with Mdm2 required for its impact on Mdm2? 
• What role does Tip60 play in the transactivation of p53-responsive genes? 
• By what mechanism does Tip60 contribute to the cellular response to 
ultraviolet irradiation? 
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3 MATERIAL 
3.1 Chemicals  
Agarose electrophoresis grade Sigma 
Ampicillin Roche 
Ammonium persulfat BioRad 
1,4-Diazobicyclo-[2.2.2]-oktan [DABCO] Sigma 
1,4-Dithiothreit [DTT] Sigma 
Bovine serum albumin (BSA) New England Biolabs 
Bromphenolblue Serva 
Calciumchloride Merck Eurolab GmbH 
Complete Mini-Protease inhibitor EDTA-free Tablets Roche Applied Science 
Complete Protease inhibitor EDTA-free Tablets  Roche Applied Science 
Chelating Fast Flow sepharose Amersham Bioscience 
Cycloheximide Sigma 
Desoxycholate  Sigma 




Ethylen diamin tetra acetate (EDTA) Roth 
Glycogen Roche Applied Science 






Methanol Bie & Berntsen 
MG132 (Proteasome inhibitor) Sigma 
Milk powder Töpfer 
N,N,N´,N´-Tetramethylendiamin (TEMED) Bio-Rad 
Protein A Sepharose (4 Cl-B) Amersham 
Protein-standard “SeeBlue® Plus 2” Invitrogen 
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Protein-standard „Benchmark“ Invitrogen 
Paraformaldehyde (PFA) Merck Eurolab GmbH 
Rotiphorese (30% acrylamide solution)  Roth 
Sodiumhydrogendiphosphate Sigma 
Sodiumhydrogenphosphate Sigma 
Sodiumchloride Riedel de Haen 
Sodiumdodecylsulfate (SDS) Merck Eurolab GmbH 
Tetracyclin Invitrogen 




Urea Bie & Berntsen 
 
3.2 Enzymes 
Alkaline phosphatase (from calf instestine) Roche Applied Science 
Expand HIFI polymerase system Roche Applied Science 
Pfu Turbo® [2,5U/µl] Stratagene 
Restriction endonucleases New England Biolabs 
T4-DNA-Ligase [30 Weiss units/µl] MBI Fermentas 
3.3 Kits 
Pure Yield™ Midi Prep System Promega 
BIORAD Protein Assay Bio-Rad 
E.Z.N.A.® Plasmid Miniprep Kit II peqlab 
Lipofectamine™2000 Invitrogen 
Firefly Luciferase Assay Kit Promega 
First strand cDNA synthesis kit Roche Applied Science 
QIAquick Gel Extraction Kit Qiagen 
LightCycler® DNA Master SYBR Green I Roche Applied Science 
SuperSignal® West Femto Maximum Pierce 
SuperSignal® West Dura Pierce 
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3.4 Consumables  
6/12/24-well cell culture dishes Greiner 
35mm cell culture plates Greiner 
sealing film for membranes Krupp 
1,5 ml and 2 ml reaction tubes Eppendorf 
1,5 ml sonication tubes “M5001-EX” Laboratory Products 
cryovials Nunc 
cell scraper Sarstedt 
sterile plastic pipettes Costar 
X-Ray films Amersham Biotech 
Gel-Blotting-Paper GB002 (Whatman-Papier)  Schleicher und Schuell 
Chamberslides LabTEK® Nalge Nunc Int. 
PCR-tubes MicroAmp® PE Biosystems 
PVDF membrane (pore size: 0,45µm) Schleicher und Schuell 
PROTRAN® Nitrocellulose Transfer Membrane (pore 
size: 0,2µm) 
Schleicher und Schuell 
cell culture flasks (162 cm2, 75 cm2, 30 cm2) Greiner 
100µl reaction tubes Applied Biosystems 
96 well frame with 8 well stripes Nalge Nunc Int. 
Optical adhesive Cover Starter Kit Applied Biosystems 
Lightcycler 20µl glass capillaries Roche 
MicroAmp™ Optical 96 well Reaction Plate with 
barcode 
Applied Biosystems  
8-16% Gradient Gels PAGEr Gold Standard  Cambrex 
4-12% Gradient Gels PAGEr Gold Standard  Cambrex 
7,5% PAGEr Gold Standard Gel Cambrex 
Syringes BD-PlastiPak 
Needles BD-PlastiPak 
nuclease free water Ambion 








name dilution application species origin manufacturer 
anti-p53 (Ab-6) (DO-
1) 1:3,000 WB mouse monoclonal Calbiochem 
anti-p53  (Ab-2)(1801) 1:3,000 WB mouse monoclonal Calbiochem 
anti-p53 (FL393) 1:300 IF rabbit polyclonal Santa Cruz Biotechnology 
anti-Mdm2 (2A10) 1:100 WB mouse monoclonal Hydridoma-Supernatant 
anti-α-Actin 1:50,000 WB mouse monoclonal Santa Cruz Biotechnology 
anti-beta-




1:1,000 WB mouse monoclonal Oncogene 
anti-EGFP 1:300 IF rabbit polyclonal Abcam 
anti-p63 (4A4) 1:300 IF mouse monoclonal Santa Cruz Biotechnology 
anti-SV40 LT-Ag 
(Pab419) 1:300 IP mouse monoclonal 
Hybridoma-
supernatant 
anti-HA-tag (HA.11) 1:1,000 WB/IF/IP mouse monoclonal Covance 
anti-Phospho-JNK 1:1,000 WB rabbit polyclonal Cell Signalling Technology 
anti-total-JNK 1:1,000 WB rabbit polyclonal Cell Signalling Technology 
anti-PARP 1:2,000 WB mouse monoclonal Oncogene 
anti-PML (PG-M3) 1:50 IF mouse monoclonal Santa Cruz Biotechnology 
anti-gamma-




name dilution manufacturer 
Peroxidase-conjugated Affinipure Goat Anti-
mouse IgG (H+L)  
1:15,000 Jackson 
ImmunoResearch 
Peroxidase-conjugated Affinipure Rabbit Anti-
mouse IgG (H+L) 
1:15,000 Jackson 
ImmunoResearch 
Alexa Fluor® 488 goat anti-mouse IgG (H+L)   1:500 Molecular Probes 
Alexa Fluor® 488 goat anti-rabbit IgG (H+L)   1:500 Molecular Probes 
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Alexa Fluor® 594 goat anti-mouse IgG (H+L)   1:500 Molecular Probes 
Alexa Fluor® 594 goat anti-rabbit IgG (H+L)   1:500 Molecular Probes 
 
3.6 Cell culture media & supplements  
Ciprofloxacin (Ciprobay®) Bayer 
Dulbecco`s Modified Eagle Medium (DMEM) Invitrogen 






DMEM (complete) contains: 10 µg/ml Ciprobay 
 50 U/ml Penicillin 
 50 µg/ml Streptomycine 
 2 µg/ml Tetracycline 
 10% FCS 
 200 µM L-Glutamine 
 
Bacterial media and supplements 
Ampicillin  [ad 200 µg / ml] Sigma 












LB- Medium 10 g Peptone, pancreatic 
digest (or Tryptone) 
 5 g Yeast extract 
 5 g NaCl 
 Fill up to 1000ml 
   
2YT-Medium 
 
16 g Peptone, pancreatic 
digest (or Tryptone) 
 10 g Yeast extract 
 5 g NaCl 
 Fill up to 1000ml 
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3.7 Bacteria and human cells 
Bacteria 
Escherichia coli DH 10 B Invitrogen 
 
Human cells 
H1299 cancer cells derived from a lung 
tumour, p53-/- 
A.J. Levine 
U2OS osteosarcoma cells, p53+/+ ATCC 
MEF pml+/+ mouse embryonic fibroblasts Marikki Laiho, Piero Pandolfi
MEF pml-/-  mouse embryonic fibroblasts Marikki Laiho, Piero Pandolfi
   
3.8 Oligonucleotides 
All oligonucleotides were synthesized by MWG Biotech, Ebersberg. 




oligo dT -Primer oligo dT 
GAPDH rev primer GCA GAG ATG ATG ACC CTT TTG GCT C 
GAPDH for primer TGA AGG TCG GAG TCA ACG GAT TTG GT 
HTATIP rev primer  GAG GAA AGG GTC TGT GTC ATA G 
HTATIP for primer  CCG TAG TCT CAA GTG TCT TCA G 
p21 for CCT GGC ACC TCA CCT GCT CTG CTG 
p21 rev GCA GAA GAT GTA GAG CGG GCC TTT 
His12for CGC GGG ATC CGC CAT GCA TCA TCA TCA TCA TCA 
TGG AGC AGG TGC AGG C 
HisNedd8for GGA GCA GGT GCA GGC CAT CAT CAT CAT CAT CAT 
ATG CTA ATT AAA GTG AAG AC 
HisNedd8rev CGC GAG ATC TAG TGA CGG ATT CTG GTG GAG G 
HIsSUMO-1for GGA GCA GGT GCA GGC CAT CAT CAT CAT CAT CAT 
ATG TCT GAC CAG GAG GCA AAA CCT 
HisSUMO-1rev CGC GAG ATC TGA TTT GAC AAC TTA CTG G 
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3.9 Plasmids and vectors  
 
pcDNA3.1-HA-Tip60 Didier Trouché (Legube et al., 2002) 
pEGFP-COP1 X.W. Deng (Yi et al., 2002) 
pC1-EGFP-Mdm2 Claudia Lenz-Bauer 
pcDNA3  Invitrogen 
pCMV-Mdm2 Bert Vogelstein  
pBP100-Luc (Freedman et al., 1997) 
pcDNA3-HA-Nedd8 Edward T.H. Yeh (Kamitani et al., 
1997) 
pcDNA3-HA-SUMO-1 Ronald T. Hay (Rodriguez et al., 1999) 
pcDNA3-His12-Nedd8 see chapter 4.3.5 
pcDNA3-His12-SUMO-1 see chapter 4.3.5 
pCDNA3-His6-Ubiquitin Dirk Bohmann (Treier et al., 1994) 
pCMV2-flag-UbcH8 Dong Er-Zhang (Kim et al., 2004) 
pcDNA3.1-His6-hUbc12 Aaron Ciechanover (Amir et al., 2002) 
pCMVSPORT6-beta-Gal Invitrogen 
pcDNA3-Myc-p14arf Yue Xiong (Zhang et al., 1998) 
pRc-p53 A.J. Levine (Lin et al., 1994) 
pcDNA3.1-HA-Tip60deltaMYST Max Koeppel 
pcDNA3.1-HA-Tip60deltaHAT Max Koeppel 
pcDNA3.1-HA-Tip60deltaExon5 Max Koeppel 
pcDNA3.1-HA-Tip60_STOP263 Max Koeppel 
pcDNA3.1-HA-Tip60_STOP390 Max Koeppel 
 
3.10  siRNA 
All siRNAs were purchased at Ambion, Inc.; 20nM, annealed,  
target sequences are given in 5’->3’ direction. All siRNAs were synthesised with a 3’-
dTdT overhang. 
siRNA name siRNA target sequence Reference 
siRNA TP53 GACUCCAGUGGUAAUCUACtt (Tiscornia et al., 2004) 
siRNA HTATIP #1 GGUGGAGGUGGUUUCACCAtt Ambion pre-designed siRNA 
siRNA HTATIP #2 GGUGGUUUCACCAGCAACUtt Ambion pre-designed siRNA 
siRNA HTATIP #3 GGAGAAAGAAUCAACGGAAtt Ambion pre-designed siRNA 
siRNA Negative 
Control #1 sequence unknown (commercial) Ambion  
siRNA TP53BP1 #1 GATACTGCCTCATCACAGTtt (Brummelkamp et al., 2006) 
siRNA MDM2 AAGCCAUUGCUUUUGAAGUUAtt (Rodway et al., 2004) 
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3.11 Buffers  
6x DNA Sample buffer: 0,25 % Bromphenolblue 
 40 % Sucrose 
 10 % Glycerol 
  
EB buffer: 10mM Tris (pH 8,5) 
  
6x Laemmli buffer: 0,35 M Tris pH 6,8 
 30 % Glycerol (v/v) 
 10% SDS (w/v) 
 9,3 % Dithiotreitol (w/v) 
 0,015 % Bromphenolblue (w/v) 
  
10x Buffer for Proteingels: 0,1 % SDS 
 25 mM Tris 
 192 mM Glycine 
  
Transfer buffer for Wet blot: 100 ml Western-Salts (10x) 
 700 ml dH2O 
 150 ml Methanol 
  
PBS++ (phosphate buffered saline) 236,9 mM NaCl 
 2,7 mM KCl 
 8,1 mM Na2HPO4  
 1,1 mM MgCl2 
 1,5 mM KH2PO4 
 1,2 mM CaCl2 
  
PBSdeficient : same as PBS++ , but without MgCl2 and CaCl2 
  
RIPA-buffer: 0,1 % Triton X-100 (v/v) 
 0,1 % Desoxycholate, DOC (v/v) 
 0,1 % SDS (w/v) 
 2 mM Tris / HCl  pH 8,5 
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 9 mM NaCl 
 1 mM EDTA 
 1,4 % Traysol 
 18,5 % Iodacetamide 
  
50x TAE-buffer: 2 M Tris 
 1 M Natriumacetate 
 0,1 % EDTA 
 
10x TBE-buffer: 40 mM
 
Tris 
 0,05 mM EDTA 
 0,89 M Boric acid 
  
Western-Salts (10x): 60,55 g  Tris 
 288,1 g Glycine 
 4 ml  10 % SDS  
(equivalent to 0,02 %) 
 ad 2000 ml H2O bidest.  
  adjust  pH to 8,3 
  
Stripping buffer 628µl beta-Mercaptoethanol 
 62,5 mM Tris-HCl pH 6.8 
 2% SDS 
 ad 100ml H2O bidest. 
 
Ponceau S solution 100 ml H2O bidest 
 0,5g Ponceau S 
 1 ml acetic acid (100%) 
   
Nickel-Pulldown lysis-buffer 0,1 M Na2HPO4/NaH2PO4 
 0,01 M Tris-HCl pH 8,0 
 10 mM Beta-Mercaptoethanol 
 8 M Urea 
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 1 tablet / 7ml Mini-EDTA free  
protease inhibitor tablet 
20mM Imidazole 
   
Nickel-Pulldown washing buffer 1 (WB1) as lysis buffer but without Imidazole 
   
Nickel-Pulldown washing buffer 2 (WB2) 0,1 M Na2HPO4/NaH2PO4 
 0,01 M Tris-HCl pH 6,3 
 10 mM Beta-Mercaptoethanol 
 8 M Urea 
 0,2% Triton-X100 
  
Nickel-Pulldown washing buffer 3 (WB3) as WB2 but without Triton-X-100 
 20 mM Imidazole 
   
Nickel-Pulldown elution buffer as WB2 but with 
 500 mM Imidazole 
   
co-IP buffer 300 mM NaCl 
 0,5% Nonidet P-40 
 5 mM MgCl2 
 10% (v/v) Glycerol 
 50 mM Tris-HCl pH 8.0 
 1 tablet /50 ml Protease-inihibitor    
EDTA-free tablet  
 ad to 100ml PBSdef. 
 
3.12  Instruments 
Name Manufacturer 
Gel Doc 200 BioRad 
GeneQuant Pro Amersham Biotech 
PCR Cycler ”Primus” MWG Biotech 
PCR Cycler „Gene Amp PCR System 2400“ Perkin Elmer 
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Gene Pulser II (Electroporation) Bio-Rad 
Western Blot Chamber Bio-Rad /Invitrogen 
X-Ray Developing-Machine „Optimax2010“ Protec 
Incubator „Hera Cell“ Heraeus 
Heat block “ Thermomixer comfort” Eppendorf 
Lightcycler 2.0® Roche Applied Science 
Realtime-PCR-system 7300 Applied Biosystems 
Table Cooling centrifuge “MIKRO 22 R” Hettich 
Cooling centrifuge “Rotina 35R” Hettich 
Table centrifuge “Biofuge Pico” Heraeus 
Rotator „PTR-30“ Grant-Bio 
UV Crosslinker „UVC-500“ Hoefer Inc. 
Luminometer „Lumistar“ BMG Labtech 
Power supply for electrophoresis Invitrogen / E-C Apparatus 
Corporation 
Freezer -80°C Siemens 
Freezer -20°C Siemens 
Vortexer „Vortex Genie2“ Scientific Industries 
Incubator for bacteria “Innova 44” New England Biolabs 
Microwave Panasonic 
PCR thermo cycler “Primus” MWG Biotech 
Shaker Labnet 
pH-meter “PHM210” Radiometer analytics 
Pipetting Aid „Pipettus“ Hirschmann Laborgeräte 
Film-sealing device „Quick Seal“  Möllerström AB 
Sterile bench  Holten /Heraeus 
Research Pipettes Eppendorf 
Sonicator “Bioruptor” Diagenode 
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4 METHODS 
 
4.1 Methods in cellular biology 
 
4.1.1 Cell culture 
The adherent cells were grown in cell culture flasks with a filter closure in a 37°C 
incubator at 5% CO2 and 95% humidity. All cell lines were maintained in Dulbecco’s 
modified eagle media supplemented with 10% fetal bovine serum, L-glutamine, 
penicillin/streptomycin, ciprofloxacin and tetracyclin. Cell culture work was done in a 
laminar flow.  
 
Passaging of cells 
Passaging of cells was performed by removing the medium followed by washing 
twice with PBSdef. to remove remaining dead cells and the rests of FBS that would 
neutralize the trypsin. Finally, 3 ml Trypsin were added and cells were incubated for a 
few minutes in the incubator until the adhesion between the cells and the cell culture 
flask was abolished. The trypsin was then neutralized by adding 10 ml of fresh 
medium, and the cells were carefully resuspended. After this step, the cells were 
counted and seeded for following experiments, just diluted and passed to new culture 
flasks (passage), or frozen. 
 
Counting of cells 
The number of cells in a suspension was determined by using a Neubauer chamber. 
A drop of the cell suspension was transferred to the chamber. The cells in the 4 fields 
(each with 16 smaller ones) were counted. The number obtained was divided by four 
and multiplied by 104, yielding the number of cells per ml of the cell suspension.  
 
Freezing and thawing of cells 
For freezing, a 182-cm2 – culture flask with confluent cells was used to obtain 3 
aliquots. Cells were washed with PBSdef, trypsinized, resuspended in new medium 
and centrifuged 5 min at 800 rpm. The supernatant was removed and the cell pellet 
was resuspended in a cold solution of 10% DMSO in FBS. 1ml aliquots were 
distributed into cryovials. After 1-3 minutes on ice, the cryotubes were wrapped into 
paper towels, which then were transferred into 50ml centrifuge tubes. The so 
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prepared tubes were then frozen in the -80°C freezer over night and subsequently 
transferred to the liquid nitrogen tank. 
For thawing cells, a culture flask with new warm medium was prepared first. An 
aliquot was removed from the liquid nitrogen, thawed in the hand, and the cells were 
transferred quickly into the flask and incubated at 37°C. On the next day, the culture 
medium was changed.  
 
4.1.2 Transient transfection of Eukaryotic Cells 
Depending on the nucleic acid to be transfected, the cells were seeded at 
concentrations of 60-70.000 cells per ml for siRNA transfection or 100.000 cells per 
ml for DNA transfection. Cells were seeded into different cell culture plates, 6/12 well 
dishes or 4well/8well chamber slides. The total amount of plasmid DNA and siRNA to 
be used was optimized for the transfection reagent. If necessary, the empty vector 
pcDNA3 or the control-siRNA was added to achieve the ideal amount of DNA or 
siRNA. For each cell line, the choice of the method to be used was done according to 
the transfection efficiency and toxicity of the different transfection reagents. All 
transfections were perfomed with Lipofectamine 2000™. 
 
Transfection with Lipofectamine 2000™ 
The following table shows the amount of transfection reagent and media used for the 
transfection of DNA and siRNA:  
Reagent Nullmedia 
for reagent 
DNA siRNA Null media 
for nucleic acids 
     
8µl  200µl 2,4 µg ------- 200µl 
4µl  200µl ------- 80pmol 200µl 
 
Procedure Time  
  
Add nucleic acid to null media  
Add Lipofectamine to null media  
Vortex  
Incubation at room temperature (RT) 5 min 
Mix both preparations and vortex  
Incubation at RT 20 min 
Add 400µl Lipofectamine 2000™-nucleoacid-mixture 
to one 6 well and rock gently 
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4.1.3  UV irradiation of cultured cells 
For the irradiation of cultured cells with UV-C light (254 nm), using the UV-
crosslinker, the cells were seeded in 6well or 12well dishes and transfected or 
treated and 36 h post transfection the cells were washed once with PBSdef. to ensure 
no liquid or proteins would impair the UV-irradiation. After carefully removing all 
PBSdef., the cell culture dishes (without lid) were put into the UV-crosslinker and the 
irradiation was performed (lasting a few seconds). The non-irradiated control cells 
were treated in the same way but were left under the sterile bench. After irradiation, 
fresh medium was added and the cells were incubated for a specific time until 
harvesting.  
 
4.1.4  Cycloheximide (CHX) treatment of cultured cells 
In order to study the half-life of a protein of interest, a cycloheximide chase 
experiment was performed. To this end, the cells were grown in 12well cell culture 
dishes and transfected after 24 h. After further 24 hours, the medium was removed 
and fresh medium with 50 µg/ml cycloheximide was added, followed by harvesting at 
different time points after treatment as described in chapter 4.2.2.  
 
4.1.5  Treatment of cultured cells with proteasome inhibitor  
For Nickel histidine pulldown assays of ubiquitinated proteins by coexpressing His-6-
Ubiquitin, the proteasome inhibitor MG132 (Sigma) (based on a small peptide) was 
added to the the cell culture medium 36 h post transfection at a concentration of 
40µM after removing the old medium. MG132 protects ubiqitinated proteins from 
degradation by the proteasome, allowing their detection in the immunostaining after 
the his-tag pulldown procedure (chapter 4.2.5).  
 
 
4.2  Biochemical and immunological methods 
 
4.2.1 Indirect immunofluorescence 
For the protein analysis by indirect immunofluorescence, 5x104 cells were seeded 
into each well of a 4well chamberslide. For 8well chamberslides, half the amount was 
used. On the next day, the cells were transfected with different plasmids. Twenty-four 
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hours after transfection, the medium was carefully removed and the cells were 
washed with PBS++, fixed with 4% paraformaldehyde in PBS++ for 15 min at RT or 
overnight at 4°C, washed again with PBS++, permeabilized with 0,2% Triton-X-100 in 
PBS++ for 15 min and washed three times with PBS++. The cells were then blocked 
with 10% FBS in PBS++ (blocking solution) for 10 min. This was followed by the 
incubation with the primary antibody (protein specific, diluted in blocking solution, 
usually 1:300) for 1 h. The cells were then washed twice shortly and once for 5 min 
with PBS++. Afterwards, the secondary antibody (species specific, diluted 1:500 in 
blocking solution) was added, followed by 30 min incubation in the dark. For the 
additional staining of the nuclei, DAPI (10 mg/ml) was diluted 1:5,000 in the 
secondary antibody mixture. After incubation the cells were washed (2x shortly and 
once for 5 min with PBS++ and the preparation was mounted using Fluoprep (0,2% 
DABCO). All incubation steps were performed at room temperature.  After at least 30 
min drying time, the slides were observed under the microscope and pictures were 
taken, using a digital camera. 
 
4.2.2 Western Blot Analysis 
Cell harvest and sample preparation 
For protein analysis by Western Blot, the cells were harvested by scraping, 
transferred into a reaction tube and centrifugated at 3000 rpm at RT for 5 min. After 
removing the supernatant, the cell pellets were dry vortexed and immediately 100 µl 
of ice-cold RIPA buffer was added followed by repeated vortexing. For the detection 
of cleaved PARP, Nickel-Pulldown lysis buffer was used. Depending on the kind of 
comb and the size of the pockets, 15 µl (17er comb), 20 µl (15er comb), 25 µl (12er 
comb) or 40µl of the sample (10er comb) were loaded.  
25 µl of 6x Laemmli buffer was added and the samples were heated at 96ºC for 5 
min. The tubes were then vigorously rocked for 15 min at 4ºC (to shear the DNA) and 
centrifugated for 10 min at 14.000 rpm (to remove cell debris). If the samples were 
not directly analyzed by SDS-PAGE, they were frozen at -20 ºC.  
 
SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis)  
The denatured and negatively charged proteins were separated in a SDS-PAGE. For 
some applications, which required an increased range of good separation, ready-to-
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use gradient gels were used that were purchased at Cambrex (USA). For the rest of 
the experiments, the gels were poured, using the BioRad or Invitrogen system. The 
gels were either 8, 10 or 12% acrylamide. The stacking gel was always 5%. The two 
parts of the gel were prepared as follows:  
 
Resolving gel (for 20ml total volume) 
 8% 10% 12% 
30% acrylamide 9,3 ml 7,9 ml 6,6 ml 
dH2O 5,3 ml 6,7 ml 8,0 ml 
1,5 M Tris-HCl pH 8,8 5,0 ml 5,0 ml 5,0 ml 
10% SDS 200 µl 200 µl 200 µl 
10% APS (ammonium persufate) 200 µl 200 µl 200 µl 
TEMED 12 µl 8 µl 8 µl 
 
After pouring, 100% Isopropanol was carefully added to obtain an equally horizontal 
surface.  
Stacking gel (5%)(for 5 ml total volume) 
30% acrylamide 830 µl 
dH2O 3,4 ml 
1 M Tris-HCl pH 6,8 630 µl 
10% SDS 50 µl 
10% APS (ammonium persufate) 50 µl 
TEMED 5µl 
 
The protein marker “Benchmark prestained” (Invitrogen) or “SeeBlue® Plus 2 
prestained” (Invitrogen) and 25µl of sample were used. The electrophoresis was 
performed at 80, 120 and 150 V subsequently, in 1x SDS-PAGE running buffer, until 
the desired separation was obtained.  
 
Western Blot (Wet Blot)  
As the method of protein transfer onto membranes, the Wet-Blot procedure was 
chosen (Nitrocellulose or PVDF). This required one Western Blot buffer (transfer 
buffer, chapter 3.11). The PVDF membrane first had to be activated by incubation in 
100% methanol for 15 s, 2 min in dH2O and 5 min in transfer buffer.  
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The sponges and whatman papers were soaked well with transferbuffer and the 
nitrocellulose membrane was put in water for a few minutes before soaking it with 







2 Layers Whatman-Paper 
Polyacrylamide gel 
Nitrocellulose membrane 





The proteins were transferred using a constant voltage of 90V for 2h (or 37V over 
night) (BioRad system) or 25V for 2h (or 18V over night) (Invitrogen system).  
 
Protein detection (Immunostaining)  
After blotting, the membrane was immediately stained with Ponceau S to check 
wether equal amounts of proteins had been transferred onto the membrane. The side 
that was in contact with the gel was marked. The nitrocellulose was then blocked in a 
solution of 5% milk powder and 0,1% Tween in PBSdef. („milk“) for 30 min, followed 
by incubation with the protein-specific antibody (diluted in milk). To save antibody, 
the membrane was sealed in a plastic film with approx. 4-5 ml milk and incubated for 
2 h at room temperature or over night at 4ºC on a shaker at 60 rpm. After this, the 
membrane was washed several times: twice 3x shortly with PBSdef. and 15 min in 
milk. The species specific antibody was added (a horseradish-peroxidase coupled 
IgG or Fab-fragment, usually diluted 1:20.000 in milk) followed by 1 h incubation on 
the shaker.  
Finally, the proteins were detected using enhanced chemiluminescence. A 1:1 
mixture of the components A (Luminol/Enhancer) and B (Peroxide solution) of 
SuperSignal West Dura (Pierce) was added to the membrane (in a polyethylene-
sealing-bag). If a higher sensitivity was required, SuperSignal West Femto Maximum 
(Pierce) was used. The excess of substrate was removed, and a sensitive film 
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(Amersham Biosciences) was exposed to the membrane and developed. The time of 
exposure necessary was dependent on the protein to be analysed and on the 
antibody dilutions used.  
 
Ponceau S-staining of Western Blots 
Using Ponceau S solution (0,1% Ponceau S (w/v) in 1% acetic acid) proteins can be 
visualised unspecifically. To this end, the membranes were washed with H2O and 
incubated for 1 min with the Ponceau S solution. After that, the membrane was 
rinsed with water until the protein bands became clearly visible. The staining was 
documented by wrapping the blot into sealing film and scanning. In order to reverse 
the staining, the blot was washed in PBSdef. /0,1% Tween. 
 
Removing antibodies from a membrane 
If a membrane had to be stained against different proteins after each other, it 
sometimes was required to reverse the previous staining in order to exclude cross-
stainings. To this end, the membrane was incubated with stripping buffer in a closed 
50 ml plastic tube for 30 min and 50°C. After that, the membrane was washed 
several times with PBSdef./0,1% Tween at RT. 
 
4.2.3  Co-immunoprecipitation 
Co-immunoprecipitation was used to study the association of Tip60 and its mutants 
with the Mdm2 protein.  
The cells were scraped off in culture medium and centrifuged in sterile 15 ml tubes 
for 5 min at 1500 rpm (RT). After taking off the medium, the cells were resuspended 
in 150 µl of PBSdef. and transferred into a 1,5 ml tube followed by centrifugation at 
3000 rpm for 5 min at RT. Next, the supernatant was removed and the cell pellet was 
resuspended in 300 µl ice-cold co-IP buffer (freshly prepared and supplemented with 
protease inhibitor (Roche)) and transferred into a 1,5 ml sonication tube made of very 
rigid plastic to ensure efficient sonication. The sonication was performed at 4°C for 
10 min in intervals at high-energy settings to shear the DNA in the sample. After 
sonication, the tubes were shortly spinned down and the cell suspension was 
transferred into a new eppendorf tube followed by centrifugation for 10 min at 14.000 
rpm and 4°C to pellet the cell debris. Thereafter, 10 µl of the supernatant was taken 
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off as an input control and mixed with 10 µl of 6x Laemmli buffer while the rest of the 
sample was split into new tubes according to the number of antibodies used to 
immunoprecipitate. Antibodies were added as follows: anti-Mdm2 (2A10): 80 µl per 
sample; anti-HA-tag (HA.11): 2µl of a 1:6 dilution in dH2O; anti-SV40 LT-Ag 
(Pab419): 20µl. The total volume of the samples was adjusted to 500 µl including the 
antibody and the tubes were rotated gently at 4°C over night. After incubation with 
the antibodies, the samples were centrifuged for 3 min at 14.000 rpm to pellet 
potentially disturbing precipitates and transferred into new tubes. Next, 30 µl of the 
protein A sepharose (50% slurry in co-IP buffer) was added, which had been 
equilibrated before by incubation in co-IP buffer for 30 min on the rotator followed by 
two wash steps in the same buffer. To ensure an equal dsitribution of protein A 
sepharose, the 100 µl pipette tips were cut to enlarge the opening. After 1 h 
incubation at 4°C on the rotator, the samples were washed 6 times with ice-cold co-
IP buffer with one washing step consisting in the centrifugation for 2 min at 4°C and 
7500 rpm, removing the medium with a syringe (RT) and addition of 500 µl ice-cold 
co-IP buffer and rotation for 5 min at RT.  
Finally, the samples were centrifuged for 1 min at 14.000 rpm and 20 µl of 6x 
Laemmli was added after taking off the supernatant. For protein separation by SDS-
PAGE, the whole sample was loaded.  
 
4.2.4 Luciferase assay 
This assay was used to study the impact of Tip60 on the transcriptional activity of 
overexpressed p53. 2 x 105 H1299 cells were seeded into 6well dishes. After 24 h, 
the cells were transfected with different expression plasmids encoding for the 
activating gene (p53) and the factors to be studied (Tip60 and p14arf). A reporter 
construct containing a portion of the murine mdm2 intron that confers transcriptional 
response to p53 upstream of the luciferase coding region (pBP100luc) was 
cotransfected. Again, after 24 h post transfection, cells were harvested in the 
medium, transferred to a 1,5 ml tube and centrifugated for 5 min at 3000 rpm (RT). 
The medium was removed and each pellet was resuspended in 150 µl of reporter 
lysis buffer (Promega, 1:5 in H2O), followed by 15 min incubation at RT with vortexing 
from time to time. During this procedure only the cell membrane was disrupted 
leaving the nucleus intact. The tubes were centrifugated at 13,000 rpm and 4ºC for 3 
min, to remove the intact nuclei and organelles. Thereafter, the supernatant was 
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directly frozen or instantly used. For the measurement of chemiluminescence 
(luciferase activity), 20 µl of cell lysate were transferred into a 96 well plate (Nunc) 
and measured in the luminometer (LUMIstar, BMG Biolabs), using the software 
LUMIstar 3.00-0, according to the manufacturers instructions. As a blank, 20µl of the 
diluted reporter lysis buffer were used. The luciferase firefly substrate was prepared 
by solving a luciferase substrate tablet in the freshly thawed luciferase assay buffer. 
The luminometer was set to inject 100µl of the substrate to each well, yielding 120 µl 
volume in total. Finally, the protein concentrations of the lysates were measured 
using the Bradford assay to normalize the luciferase activity (see chapter 4.2.5).  
 
4.2.5 Nickel-histidin-tag-pulldown assays 
The Nickel-Histidine-Tag-pulldown method is based on the Nickel-chelating 
characteristic of a 6x or 12x histidine strech in a polypeptide. By adding a repeat of 
histidines to a protein of interest, either on the N-or C-terminus, it can be used to 
specifically extract (“pull down”) this protein by using specially modified and 
“Ni2+loaded” sepharose.  Here, this method was used to extract proteins from a cell 
lysate that had been modified with ubiquitin-like proteins as SUMO-1, Nedd8 or 
Ubiquitin itself. 
  
Figure 4.1: Nickel-His-tag pulldown principle 
Chelate complexes between adjacant histidine side chains and Ni-ions, immobilized at a NTA-matrix 
(taken from the handbook „the QIAexpressionistTM“ from Qiagen, 2003). 
4 out of 6 ligand binding sites of the Ni2+ (black) are bound by nitrilo tri acetic acid (NTA; red), which is 
coupled to the sepharose. The remaining 2 sites are complexed by 2 histidine side chains (blue).  
 
Cells were harvested 36 h post transfection and lysed in lysis buffer (8 M Urea, 0,1 M 
Na2HPO4/NaH2PO4, 0,01 M Tris-HCl pH 8.0 and 10 mM beta-mercaptoethanol 
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supplemented with 20mM imidazole + protease inhibitor mini tablets EDTA-free 
(Roche), the cell debris was pelleted by centrifugation at 14.000 rpm for 15 min at RT 
and the supernatant was subjected to preclearing with chelating fast flow sepharose 
(Amersham Bioscience). The fast flow sepharose was equilibrated first, by 
centrifugation at 500x g followed by a washing step with dH2O and resuspension in 
one volume of lysisbuffer + protease inhibitor.   
Subsequently the lysate was incubated for two hours with High Performance Nickel 
sepharose (Amersham Bioscience) (equilibrated as the fast flow sepharose) on a 
rotator, followed by one 5 min washing step with 500 µl washing buffer 1 (WB1) 
(lysisbuffer without imidazole), 2 washing steps with WB2 (8 M Urea, 0,1 M 
Na2HPO4/NaH2PO4, 0,01 M Tris-HCl pH 6.3, 10 mM beta-mercaptoethanol suppl. 
with 0,2% triton X-100) and 2 washing steps with WB3 (WB2 without triton X-100 + 
20mM imidazole). The His-tagged proteins were eluted with 100 µl elutionbuffer 
(WB2 without triton X-100 + 500mM imidazole), 6x Laemmli buffer was added and 
the samples were subjected to SDS-PAGE and Western blot analysis. All steps were 
carried out at RT.  
 
4.2.6 Measurement of protein concentrations  
Bradford method 
5µl cell lysate were transferred to a 1 ml plastic cuvette and mixed with 1 ml 
Bradford-reagent (BioRad, 1:5 in H2O). The absorbances were measured at 595 nm 
against a blank containing no lysate but equivalent amounts of lysis buffer and 
Bradford reagent. The absorbances correlated with the protein concentration and 
were used to normalize the values obtained in the luciferase assays.  
 
4.3 Methods in molecular biology 
 
4.3.1 Transformation of E. coli 
The introduction of plasmid DNA into bacteria (transformation) to produce a high 
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Preparation of chemocompetent E.coli  
5 ml LB medium were inoculated with one single colony of E.coli DH10B and 
incubated overnight at 37°C with shaking. 200 ml LB were then inoculated with 0,5 ml 
of the overnight culture and shaken at 37°C until the optical density (590nm) 
achieved 0,6 (log phase of bacterial growth). The culture was chilled on ice for 10 
min and cells were harvested by centrifugation at 3,000 rpm, 5min at 4°C. The 
bacteria were resuspended in 50 ml of ice-cold, sterile 0,1 M MgCl2, followed by 20 
min incubation on ice. The suspension was centrifugated again and the cells were 
resuspended in 5 ml of sterile 0,1 M CaCl2, followed by one hour incubation on ice. 
The suspension of competent cells was then brought to 15% in glycerol, distributed in 
50µl aliquots, frozen in liquid nitrogen and stored at -80°C.  
 
Chemical transformation of competent E.coli  
Chemocompetent bacteria were transformed by the temperature-shock method. 1µl 
plasmid was transferred to a 1,5 ml tube together with 20µl of bacteria suspension. 
The tube was incubated on ice for 30 min, then for 2 min at 42°C and again on ice for 
1 min. For selection with ampicillin (that inhibits the synthesis of the cell wall), the 
mixture was directly distributed over an ampicillin-LB plate. For selection with 
kanamycin (inhibitor of the 30S ribosomal subunit) the bacteria suspension was first 
incubated in 500 µl LB-medium at 37°C for 1 h (to enable the transcription and 
translation of the kanamycin inactivating enzyme), before spreading onto a 
kanamycin-LB-agar plate. The agar plates were incubated overnight at 37°C. 
 
Electroporation of E.coli 
This method is more efficient than the chemical transformation and was used for 
ligated DNA, during the cloning procedure.   
0,5µl of the ligation sample was gently mixed with 8 µl electrocompetent E.coli 
(ElectroMAX DH10B, Invitrogen) in a pre-chilled 0,1 cm Gene-Pulser-Cuvette 
(BioRad). The cuvette was immediately transferred back on ice. The electroporation 
was perfomed using the the Gene-Pulser-Controller at 1,7 kV, 200 Ω and 25 µF 
followed by the addition of 250 µl LB-Medium to the bacterial suspension and treated 
as described above. 
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After striking out the bacteria on an agar plate, the plates were incubated at 37°C 
overnight.  
  
4.3.2 Isolation of plasmid DNA 
For the purification of plasmid DNA from a 2 ml bacterial suspension, the E.Z.N.A.® 
Plasmid Miniprep Kit I (peqlab) was used. For the preparation of higher amounts of 
DNA, 15-30 ml bacteria-suspensions and the E.Z.N.A. Plasmid MiniPrep Kit II or the 
Pure Yield™ Midi Prep System (Promega) were used. All kits were used according to 
the manual’s instructions.  
The procedure is based on the alkaline lysis of bacterial cells, cleaning and 
preparation of the lysate, adsorption of DNA to silica membranes in the presence of 
high salt, washing and elution of DNA with EB (elution buffer; 10 mM Tris-HCl, 
pH8,5).  
 
4.3.3 Measurement of DNA/RNA concentration 
To determine the concentration of a DNA or RNA preparation, 400µl of a 1:100 
dilution (in water) was transferred into a quartz cuvette and the absorbance (260nm) 
was measured using the GeneQuantProII-photometer (Pharmacia Biotech). The 
concentration of dsDNA sample was calculated using a factor of 50 (1 absorbance 
unit corresponded to 50 µg/ml) and a factor of 40 was used for the RNA samples. 
 
4.3.4 Polymerase chain reaction (PCR) 
The PCR is used to specifically amplify a DNA sequence that is located in between 
two oligonucleotide fragments (Primer), which bind complementary to DNA. First, the 
template DNA is denatured by the application of heat (>90°C) into single strands. 
This phase is followed by annealing of the primers to their target sequences, which 
subsequently is amplified by the DNA-Polymerase through elongation of the Primers. 
This sequence of reactions is repeated several cycles. The new products are 
themselves used as new templates leading to an exponential amplification of DNA-
fragments. For the amplification of larger DNA-fragments, the Expand-HIFI 
polymerase (EHF) system was used. The polymerase mix contained in this system 
allows even the amplification of long sequences of DNA (>1kb) with a relatively low 
error rate. 
 
Methods                                                                                                                      39 
PCR-sample: 5,0 µl  10x reaction buffer 
 0,5 µl  dNTP-Mix [20 mM each] 
 1,0 µl  Forward primer [50 ng / µl] 
 1,0 µl  Reverse primer [50 ng / µl] 
 200 ng  DNA-template 
 1,0 µl  EHF Enzyme-Mix [3,5 U / µl] 
 ad 50 µl  dH2O 
The PCR was performed in programmable PCR machines in special thin wall PCR 
tubes (Applied Biosystems) 
 
PCR-Program:  94°C 3 min. Denaturing  
  94°C 30 s Denaturing  
40x 55°C 30 s Annealing  
  70°C 2,5 s Elongation 
  70°C 7 min Elongation 
  4°C ∞ End of reaction, storage  
 
 
4.3.5 Cloning of pcDNA3-His-12-Nedd8 and pcDNA3-His-12-SUMO-1 
His12-Nedd8 was amplified from pcDNA3-HA-Nedd8 in a first step with the primers 
HisNedd8for 5’-CGC GGG ATC CGC CAT GCA TCA TCA TCA TCA TCA TGG AGC 
AGG TGC AGG C-3’ and HisNedd8rev 5’-CGC GAG ATC TAG TGA CGG ATT CTG 
GTG GAG G-3’ followed by an amplification from the first product with the primers 
His12for GGA GCA GGT GCA GGC CAT CAT CAT CAT CAT CAT ATG CTA ATT 
AAA GTG AAG AC and HisNedd8rev. The PCR product containing the His-tagged 
Nedd8 was cloned into pcDNA3 using XbaI and BamHI.  
His12-SUMO-1 was generated by amplifying the SUMO-1 sequence from pcDNA3-
HA-SUMO-1 with the primers His-SUMOfor 5’-GGA GCA GGT GCA GGC CAT CAT 
CAT CAT CAT CAT ATG TCT GAC CAG GAG GCA AAA CCT-3’ and SUMO-1rev 
5’-CGC GTC TAG AGA TTT GAC AAC TTA CTG G-3’. After that, the product was 
used for another amplifcation with the primers His-for and SUMO-1rev and purified 
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4.3.6 DNA restriction digest 
The treatment of DNA with restrictionendonucleases represents a fast and simple 
method to check or modify plasmids during the construction of new vectors. An 
analytic sample is used for the fast check of plasmids. The complete sample is 
loaded onto an agarose gel after the incubation at 37°C and addition of 2µl DNA-
sample buffer (6x).  
The preparative sample is used to produce suitable fragments of DNA that are later 
inserted into a new vector. In some cases, the DNA fragment of interest has to be 
purified by separation on a agarose gel followed by its extraction. 
 
Analytical sample: 7µl plasmid-DNA from mini-prep (≅ 1-2µg DNA) 
 2µl BSA (bovine serum albumin) 
 2µl 10x buffer 
 1µl restriction endonuclease(s) 
 ad 20µl dH2O 
 
Preparative sample: 10µg  plasmid-DNA from mini-prep (≅ 1-2µg DNA) 
 10µl  BSA (bovine serum albumin) 
 10µl  10x buffer 
 10µl  restriction endonuclease(s) 
 ad 100µl  dH2O 
 
The restriction endonucleases are provided with an adequate 10x reaction buffer and 
if applicable, with BSA which stabilizes the enzymes. In case, two enzymes exhibit 
different temperature optima, the treatment has to be perfomed sequentially.  
4.3.7 Fill-in reaction of non-compatible, overhanging DNA ends 
If two DNA molecules cannot be treated with restriction endonucleases in a way 
enabling them to be ligated together, it is possible to fill in the overhanging DNA ends 






 purified DNA in EB-Buffer  
(after Phenol/Chloroform-Extraction: 4.3.10) 
 5 µl  10x Pfu-Buffer 
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 1 µl  dNTP-Mix [20mM each] 
 1 µl  Pfu-Polymerase [2,5U/µl] 
Incubation 30 min. at 70°C. 
 
4.3.8  Dephosphorylation of vector-DNA 
In order to avoid the religation or oligomerization of vectors that exhibit compatible 
ends following a restriction digest, the 5’-ends of the linearized vectors were treated 
with alkaline phosphatase (calf intestine phoshatase, CIP). To this end, 2µl CIP 
(20U/µl) were added to the restriction digest sample after 1 h incubation. The sample 
was incubated for 1 h more and purified in analogy to insert-DNA by 
Phenol/Chloroform extraction. 
 
4.3.9  Ligation 
The T4-DNA ligase was used to form a phospodiester bond between the 3’-OH and 
the free 5’-phosphate residues of the cohesive ends of insert and vector DNA. This 
allows the insertion of an additional DNA-fragment into an existing vector. Here, it is 
of advantage to shift the molar ratio of the different DNA molecules towards the 
insert.  
 
sample: 6 µl insert-DNA (ca. 1,5µg) 
 1 µl vector-DNA (ca. 0,3 µg) 
 1 µl ATP [100 µM] 
 1 µl T4-DNA-Ligase 
 1 µl 10x ligation buffer 
 
In order to estimate the ratio of religated vectors to ligated plasmids, a control ligation 
with only the vector was perfomed in parallel. Ligations were incubated over night at 
16°C or for 2 h at RT. 
 
4.3.10  Electrophoretic separation of DNA in an agarose gel 
DNA fragments can be separated electrophoretically based on their size and 
dependent on the agarose concentration. For the gel electrophoresis performed in 
this work, 0.8 – 2 % agarose gels were used, depending on the DNA fragment to be 
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separated. The gels contained ethidium bromide at a concentration of 0,1µl /ml (1% 
stock solution). The DNA-samples were loaded on the gel after adding 6x  DNA-
sample buffer. To identify the size of the DNA fragments, a DNA-size-marker was 
loaded on the gel. After the electrophoretic separation of the DNA fragments (30 min 
at 120V), the gel was observed under UV irradiation in a gel doc system (BioRad), 
showing the DNA that incorporated the ethidium bromide.  
 
4.3.11  Isolation of DNA from agarose gels 
For the isolation of DNA-fragments from agarose gels, the desired DNA fragments 
were first cut out under UV light using a scapel and subsequently transferred to a 1,5 
ml tube. After weighing the gel piece, the purification was performed with the 
QIAquick™ gel extraction kit according to the manual. In the last step, the DNA was 
eluted from a silica column using EB-buffer. 
 
4.3.12 Phenol Extraction of DNA  
During cloning and after digestion of the DNA (and dephosphorylation of the vector), 
phenol extraction was performed to purify the DNA from enzymes and buffers. One 
volume of phenol (Roth) was added to the DNA solution to be purified, followed by 
vigorous mixing and centrifugation (13,000 rpm, 3 min at 4°C). The upper aqueous 
phase, containing the DNA, was transferred to a new tube and mixed with a volume 
of CIA (chloroform/isoamyl-acohol 24:1) This mixture was shortly centrifuged (in a 
table centrifuge) and the upper aqueous phase was transferred to a new tube. This 
was followed by an ethanol precipitation.  
 
4.3.13  DNA Ethanol Precipitation 
To precipitate and purify DNA after a phenol-extraction (during cloning), the following 
components were added to the DNA solution and mixed: 
1 µl gycogen (used as carrier; 10 mg/ml) 
1/10 volume 3 M sodium acetate (pH 6,2) 
2,5x volume 100% ethanol 
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This solution was centrifuged for 30 min at 13,000 rpm and 4°C, the pellet was 
washed in 250 µl 70% ethanol, dried, and resuspended in 10 µl EB (elution buffer, 
10mM Tris-HCl, pH 8,5). This purified DNA was then used for ligation. 
 
4.3.14  DNA sequencing 
For DNA sequencing the dideoxy chain termination technique (Sanger et al., 1977) 
was used. This method is based on the cyclic polymerization of the DNA of interest 
with a specific primer and a mixture of dNTPs and ddNTPs (labelled with four 
different fluorescent groups). The incorporation of a ddNTP causes the termination of 
the DNA polymerization due to its lack of the 3’-OH group. In this way, DNA 
fragments of different sizes are obtained and separated in a electric field.  
For DNA sequencing, 1-2 µg of DNA was precipitated by ethanol precipitation and 
the dried DNA pellet was sent to MWG Biotech, Ebersberg, Germany, together with 
the appropiate sequencing primer in an extra tube.  
 
4.3.15  Phenol Extraction of RNA 
The RNA was extracted from the cells 36 h after transfection with plasmids or siRNA 
using the Trizol® reagent (Invitrogen). 
The cells were scraped in culture medium and centrifuged in a sterile 15 ml tube for 5 
min at 1500 rpm. The cell pellet was resuspended in 150 µl PBSdef. and transferred 
into a 1,5ml tube. The tube was centrifuged for 5 min at 3000 rpm (RT), the PBSdef. 
was removed and 700 µl Trizol® reagent (a mixture of phenol and guanidine 
isothyocyante) was added after dry vortexing the tube. The pellet was resolved by 
carefully pipetting up and down, followed by another vortexing step. After 5 min 
incubation at room temperature, 150 µl chloroform were added and the tube was 
shaked very vigorously for 15 sec, followed by 3 min incubation at room temperature. 
After centrifugation at 10.000 g, for 15 min at 4°C, different phases were separated: 
an organic phase containing proteins, an interphase containing DNA and an aqueous 
upper phase containing the RNA. The latter was transferred into a new tube and the 
RNA was precipitated by adding 500 µl isopropanol, mixing incubating for 10 min at 
RT and centrifugating at 10.000 g, for 10 min, at 4°C. The pellet was washed with 
1ml 75% ethanol and resuspended in 20 µl nuclease free water (Ambion). 
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The RNA concentration was measured as described in 4.3.3. The RNA was 
distributed in aliquots and stored at -80°C or directly used for reverse transcription 
(for qRT-PCR) 
 
4.3.16 Reverse transcription 
For reverse transcription, the First strand synthesis Kit from Roche was used. After 
measuring the RNA concentration, 1µg of RNA was used for reverse transcription. As 
primers, oligo-dT- primers were used that unspecifically bind to the polyA-tail of all 
cellular polyadenylated mRNA species.  
 
Reverse transcription reaction (for Applied Biosystems and Roche Lightcycler): 
RNase inhibitor 1µl 
RT-Primer 1µl 
Total RNA 1µg 
10x First strand synthesis buffer 2µl 
AMV Reverse transcriptase 0,8µl 
MgCl2 2µl 
Sterile H2O ad 20µl 
Total volume 20 µl  
 
Reverse transcription program 
25ºC 10 min 
42ºC 60 min 
99ºC 5 min 
4ºC ∞ 
 
4.3.17 Quantitative realtime-PCR (qRT-PCR) 
The use of conventional PCR methods to quantify the amount of a certain mRNA 
species or other nucleic acids has the disadvantage of being not very accurate and 
laborious. This weakness has been overcome by the advent of the new quantitative 
Real-time PCR methods that make up an increasing percentage of PCR applications. 
The SYBR Green method exploits the characteristic of the SYBR green molecule to 
specifically bind to doublestranded DNA molecules that form upon amplification of a 
certain template (reviewed in Zipper et al., 2004). When bound to doublestranded 
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DNA, the SYBR Green molecule emitts green light (λmax = 522 nm), when it is 
excitated by a specific wavelength (λmax = 498 nm). With each PCR cycle, the number 
of doublestranded products increases and more SYBR Green can bind to the DNA 
(Figure 4.2). The Realtime PCR machine tracks the amount of fluorescence at the 
end of each PCR cycle and plots these values against the cycle number, allowing the 
user to determine the logarithmic phase of amplification. In this phase, conclusions 
can be drawn from the time the fluorescence exceeds a certain threshold to the initial 
amount of template in the sample. Usually, two kinds of Realtime PCR quantification 
are distinguished; the relative quantification and the absolute quantification. A 
disadvantage of the SYBR Green method is the unspecific binding of SYBR green to 
all dsDNA, including potential unspecific PCR products. Therefore, a melting curve 
has to be performed to control the melting temperatures of the PCR products. 
Furthermore, the identity of the PCR products were checked on an agarose gel.  
 
 






Figure 4.2 : Mechanism of SYBR green based Realtime PCR  
(A) Step 1: Free SYBR green molecules and denatured DNA molecules (Template and Primers)  
(B) Step 2: Upon Primer binding, the first SYBR green molecules can bind and are now capable of 
emitting light when excitated.  
(B) Step 3: Amplification of the template leads to proportionally increased binding of SYBR green 
molecules to the DNA and increase of fluorescence. (Pictures taken from the homepage of Roche 
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The quantitative Realtime analysis was performed on two different systems: 
 1) Lightcycler 2.0 (Roche) (Marburg) 
 2) 7300 Real time PCR system (Applied Biosystems) (Odense) 
The Realtime PCRs that were run on the Lightcycler were performed using capillaries 
in a carousel.  
The machine of Applied Biosystems is based on a 96well plate basis.  
 
Capillary preparation (Lightcycler) 
The mastermix (18 µl) was pipetted into the precooled capillaries (in a metal-cooling 
block). After that, the template was added to the capillary (2 µl), followed by sealing 
with a plastic lid and centrifugation at 3000 rpm for 5 s at 4°C. The samples were 
introduced into the light cycler carousel without applying force and were pressed 
carefully into it. The carousel was subsequently put into the light cycler and the 
machine was started.  
To check the Realtime PCR products on an agarose gel, the capillaries were opened, 
and put upside down into a 1,5 ml tube followed by short centrifugation (20-30 s) at 
500 rpm.  
 
Mastermix for quantitative Realtime PCR (Roche Lightcycler) 
 
Mastermix 5x 4,0 µl  
forward-Primer (1:20)   1,3 µl 
reverse-Primer (1:20) 1,3 µl 
dH2O 8,4 µl 
total volume 18,0 µl 
 






Hold (h:min:s) Ramp (C°/s) Aquisistion 
Mode 
Denaturation: 95 00:10:00 20 none 
Amplification: 95 00:00:10 20 none 
 60 00:00:08 20 none 
 72 00:00:30 20 single 
Melting Curve 95 00:00:00 20 none 
 65 00:00:20 20 none 
 95 00:00:00 0,1 continuous 
Cooling 37 00:00:00 20 none 
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The special construction of the lightcycler and the thin capillary walls allowed very 
short program steps.  
 
Plate preparation for Realtime PCR (Applied Biosystems): 
First, the plate was put on ice and the mastermix was prepared. The cDNA was 
diluted 1:10 and then 2,5 µl were used as template per well. For the standard curve, 
the cDNA was first diluted 1:2 and then in 4 serial dilution 1:4 : 
6µl cDNA + 6µl H2O -> 3µl + 9µl H2O ->… 
The cDNA was pipetted into the plate, then the mastermix was added followed by the 
application of a sealing adhesive cover to avoid evaporation of reagents from the 
reaction. Finally, the plate was centrifugated shortly to spin down drops of reagent.  
 




Nuclease free Water 3,5µl 
Forward-Primer (5µM) 3,25µl 
Reverse-Primer (5µM) 3,25µl 
End Volume:  22,5µl 
 
PCR program used for the amplification of GAPDH/p21 (Applied Biosystems) 
Degree Time Comments Cycles 
95°C 10 min DNA Polymerase 
Activation 
1 
95°C 15 sec DNA melting 
60°C 15 sec Primers annealing 
72°C 1 min 15 sec Extension 
40 
  Dissociation stage 1 
 
Data analysis at the computer (Roche Lightcycler) 
The quantification was performed using the Lightcycler® 2.0 software, with the 
relative quantification setup (calibrator normalized relative quantification without 
efficiency correction) according to the manual.  
 
Data analysis at the computer (Applied Biosystems) 
The quantification was performed using the SDS-Program (Applied Biosystems). A 
relative quantification was performed, but the amounts of PCR product were 
correlated to a standard curve, derived from different dilutions of one sample.  
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4.3.18 Suppression of gene expression by RNA interference 
The overexpression of proteins in the cells often does not lead to mRNA and protein 
levels that really reflect the actual physiological level of the protein of interest. Apart 
from that it is also very important to study the effect in the absence of a particular 
protein. To overcome this problem, several methods have been developed to 
abrogate the expression of a gene of interest.  The gene knockout, a deletion of one 
or both allels of a gene of interest in live animals with subsequent cultivation of the 
cells, is a very laborious and time-consuming method. Over the past decade a new 
method emerged, termed RNA interference (RNAi). This method exploits a naturally 
occurring phenomenon that was originally discovered in plants in the year 1990 
(Napoli et al., 1990). In the last few years, it has become clear that RNAi occurs in 
both plants and animals and has roles in viral defense and transposon silencing 
mechanisms. 
The short interfering RNAs are transfected by Lipofection (Lipofectamine 2000™), 
using the protocol and siRNA amounts decribed in 4.1.2. After entering the cell, the 
duplex molecule is unwound by a helicase and integrated into the RNA induced 
Silencing complex, called RISC. After its integration into RISC, the siRNAs anneal to 
their target mRNA and the RISC component Argonaute protein cleaves the mRNA, 
thereby preventing its translation (reviewed (Mittal, 2004).  
For the design of a highly efficient siRNA that does not provoke too many unspecific 
effects, certain rules have to be considered. Here only a few are mentioned: 
1) The siRNA target sequence shoud not exhibit sequence similarity with any 
other known mRNA, e.g. longer strechtes of identical bases. This is checked 
for with the BLAST for short, nearly exact matches at NCBI. 
2) The siRNA sequence should have an overall low to medium G+C content 
(30-50%). 
3) Internal repeats or palindromes should be avoided. 
 
The siRNA used in these experiments were either designed by a special algorithm 
that was developed by Ambion Inc. that incorporates several rules, or taken from 
publications that had already proven their efficacy.  
Chemically synthesized short RNA moleclues of 19-21 bases that are self-
complementary and form a RNA-duplex are now used for the specific suppression of 
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gene expression (Elbashir et al., 2001). Moreover, the siRNAs exhibit a 2 nucleotide 
overhang (typically: dTdT) at the 3’ end. 
The efficiency of the siRNA was evaluated by qRT-PCR and Western Blot analysis if 
applicable. 
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5 RESULTS 
5.1 Tip60 as a modulator of p53 and Mdm2 protein levels 
A large scale siRNA screen has identified the Tip60 protein as an essential factor for 
the p53-dependent cell cycle arrest (Berns et al., 2004). This finding, together with 
the fact that Tip60 acts as a histone acetyl transferase, implicates that Tip60 
functions by virtue of its activity as a transcription cofactor. However, it has recently 
been shown that Tip60 interacts with Mdm2, leading to the degradation of Tip60 
(Legube et al., 2002). This prompted us to ask, whether Tip60 might also contribute 
to p53 activity by directly antagonizing the activity of Mdm2 towards p53. 
 
5.1.1 Overexpression of Tip60 leads to increase in p53 and Mdm2 protein 
levels  
The Mdm2 oncoprotein and its target p53 are very unstable proteins, which is mainly 
due to the E3-Ubiquitin-ligase activity of Mdm2 towards p53 and itself. Since Tip60 
and Mdm2 can form a complex (Legube et al., 2004), we sought to further investigate 
the role of Tip60 in the regulation of Mdm2. First, we overexpressed Tip60 in U2OS 
(derived from an osteosarcoma; TP53+/+) cells and performed immunoblot analysis to 
determine the endogenous protein levels of Mdm2 and p53 under these 
circumstances (Fig. 5.1A). Tip60 overexpression led to an increase of Mdm2 and p53 
protein levels (compare lanes 1+2). However, in comparison, p14arf was more potent 
in elevating the levels of Mdm2 and p53 (lane 3).  
 
5.1.2 Tip60 overexpression results in an increased protein half-life of Mdm2 
Next, we were interested in how Tip60 overexpression was capable of stimulating the 
accumulation of Mdm2 and p53. Principally, there are different scenarios that could 
be envisioned to explain the increase in Mdm2 and p53 protein levels. Tip60 could 
either act to induce the transcription of these genes or affect their protein stability. 
Since p53 and Mdm2 are mainly regulated at the protein level, cycloheximide (CHX) 
chase experiments were performed to reveal the impact of Tip60 on the half-life of 
Mdm2 (see chapter 4.1.4). Cycloheximide is an antibiotic, produced by Streptomyces 
griseus, that specifically inhibits the translation of mRNAs, thereby stalling the cellular 
protein biosynthesis. H1299 cells (TP53-/-) were transfected either with empty vector, 
Mdm2, or a combination of Mdm2 with Tip60 or p14arf. While no more Mdm2 protein 
was visible after 3 hours of CHX treatment in the cells transfected with the vector 
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alone (Figure 5.1B, lane 1-6), the coexpression of Tip60 as well as p14arf led to a 
strong stabilisation of Mdm2 (lanes 7-12). We conclude that Tip60 is capable of 
blocking the degradation of Mdm2.  
 
5.1.3 Tip60 reverses the destabilization of p53 by Mdm2 
The next question was, whether Tip60 could specifically interfere with the Mdm2-
mediated degradation of p53. For this purpose, p53 was coexpressed in H1299 cells 
(TP53-/-) either alone with Mdm2 or in addition with Tip60 and p14arf. H1299 cells are 
derived from a human adenocarcinoma of the lung and are particularly well suited for 
the study of the Mdm2-p53 system, as they do not contain p53 and only very low 
levels of Mdm2, which could interfere with the effectors to be studied.  
As expected, the coexpression of Mdm2 and p53 led to a reduction of p53 protein 
levels due to Mdm2-mediated degradation of p53 (Figure 5.1C, compare lane 2 and 
5). However, upon coexpression of Tip60, p53 levels were partially restored while 
Tip60 overexpression in the absence of Mdm2 had no effect (lanes 2+3 and 5+6). 
p14arf expression led to an even stronger increase of p53 levels. Moreover, the 
Mdm2 levels were strongly increased when Tip60 was coexpressed as in the case of 
p14arf (lanes 5-7). These data imply that Tip60 is capable of inhibiting the Mdm2-
mediated degradation of p53. This is supported by the fact that Tip60 overexpression 
in the absence of Mdm2 does not alter the p53 protein levels (lanes 2 and 3).  
 
5.1.4 Tip60 mRNA levels are strongly reduced upon siRNA-mediated 
knockdown of HTATIP expression 
The overexpression of proteins to study their role in the cell is initially very helpful but 
does not necessarily reflect the physiological situation. Therefore, we studied the 
effect of  specific siRNA-mediated HTATIP knockdown. To this end, three different 
siRNAs were designed and subsequently tested in regard to their efficiency in 
suppressing the expression of HTATIP. The siRNAs suppress the expression of all 
Tip60-mRNA species to avoid interference between the splicing variants. U2OS cells 
were transfected with equal amounts of siRNA followed by RNA extraction after 48 h, 
reverse transcription and qRT-PCR analysis (chapter 4.3.16 and 4.3.17). As shown 
in Figure 5.2, the siRNAs differ in their knockdown effiency. Tip60-siRNA#3 had the 
most pronounced effect on Tip60-mRNA levels, leading to a reduction of over 80%. 
Therefore, knockdown experiments were were carried out with Tip60-siRNA#3. 





























Figure 5.1 Impact of Tip60 on Mdm2-mediated degradation of p53.    
(A) Impact of Tip60 on endogenous p53 and Mdm2 protein levels. U2OS cells were transfected either 
with empty vector or expression plasmids for HA-Tip60 and p14arf. Twenty-four hours post 
transfection, the cells were harvested by scraping, lysed in RIPA buffer, supplemented with Laemmli 
buffer and subjected to SDS-PAGE followed by protein detection by immunoblot analysis. The position 
of Mdm2 is shown by an arrow; non-specific bands observed independently of Mdm2 are labelled by 
asteriks. (B) Impact of Tip60 on the protein half-life of Mdm2. H1299 cells were transfected with the 
indicated plasmids; 24 h post transfection, the cells were treated with 50µg/ml cycloheximide to inhibit 
protein translation. The cells were then harvested at the indicated time points after cycloheximide 
addition and further processed as described in (A). A longer exposure is shown to reveal the stability 
of endogenous Mdm2. (C) H1299 cells were transfected with the indicated plasmids and processed as 
in described in (A). 
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Figure 5.2: Comparison of different Tip60 siRNAs in their knockdown efficiency. 
U2OS cells were transfected with a Control siRNA and three different siRNAs against Tip60. After 
48h, the cells were harvested followed by RNA extraction and specific reverse transcription of GAPDH 
(control gene) and Tip60 mRNAs. To determine the amount of Tip60 mRNA, a quantitative Realtime 
PCR was performed. The values for HTATIP were set in relation to GAPDH and the control siRNA 

















Figure 5.3: Impact of Tip60-siRNA on the levels of Mdm2 and p53 in U2OS cells.  
U2OS cells were transfected with the indicated siRNAs and harvested 36h later in RIPA/laemmli 
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5.1.5 siRNA-mediated knockdown of HTATIP expresssion decreases the 
protein levels of Mdm2 
Next, we were interested in whether the removal of endogenous Tip60 by siRNA-
mediated gene knockdown would have the opposite effect on the Mdm2 and p53 
levels as its overexpression. Therefore, U2OS cells were transfected with siRNAs 
targeting Tip60- and p53-mRNA (positive control) as well as a randomized siRNA 
preparation (negative control). While the siRNA against Tip60 led to a reduction of 
endogenous Mdm2 protein levels, the p53 protein levels remained unaltered (Figure 
5.3, lane 3). siRNA targeting the p53-mRNA also led to a reduction of Mdm2 protein 
levels which is most likely due to a lack of transcriptional activation of MDM2-
promoter by p53 (lane 2). These results suggest that endogenous Tip60 is indeed 
required for the maintenance of basic Mdm2 protein levels. However, the 
experimental conditions used here did not allow us to see a negative effect of Tip60- 
siRNA on p53 levels.  
 
5.2 Impact of Tip60 on posttranslational modifications of p53 and 
Mdm2 
5.2.1 The stabilization of p53 by Tip60 is not due to inhibition of Mdm2-
mediated ubiquitination of p53  
It appeared conceivable that the stabilization of Mdm2 and p53 by Tip60 is due to 
interference of Tip60 with the ubiquitination of Mdm2 and p53. To test this, we 
performed a Nickel-His-Tag-pulldown after coexpressing the E2-conjugating enzyme 
UbcH8 and His-tagged Ubiquitin (later termed Ubiquitin-CS for "conjugating system") 
together with Mdm2 and p53. As shown in Figure 5.4, the coexpression of the 
Ubiquitin-CS with p53 and Mdm2 led to the occurrence of slower migrating bands, 
corresponding to the ubiquitinated forms of p53 (lane 4). As p14arf has been 
described to inhibit the ubiquitination of p53 (Honda and Yasuda, 1999), we used it 
as a positive control. Indeed, a change in the ubiquitination pattern of p53 with fewer 
slower migrating bands was observed (lane 5). However, parallel overexpression of 
Tip60 did not influence the appearance of ubiquitinated p53 (lane 6). From these 
data, we conclude that, unlike p14arf, Tip60 does not interfere with the Mdm2-
mediated ubiquitination of p53, at least in the system under study here. The 
stabilization of Mdm2 and p53 therefore appears to occur at a step between the 
ubiquitination and the proteasomal degradation.  
















Figure 5.4: Impact of Tip60 and p14arf on Mdm2-mediated Ubiquitination of p53.  
U2OS cells were transfected with the indicated combinations of expression plasmids. Thirty-six hours 
post transfection, the cells were treated with 40 µM of the proteasome inhibitor MG132 for 4 h. 
Subsequently, the cells were harvested, followed by a Nickel-His-tag pulldown. The samples were 
subjected to SDS-PAGE with subsequent protein detection by immunoblotting.  
 
5.2.2 Tip60, but not p14arf inhibits the Mdm2-mediated neddylation of p53 
Mdm2 not only acts as an E3-ligase for Ubiquitin, but also mediates the neddylation 
of p53, thereby inhibiting its transcriptional activity (Xirodimas et al., 2004). So far, 
the mechanisms regulating the neddylation activity of Mdm2 are unknown. Therefore, 
we asked whether Tip60 might affect p53-neddylation by Mdm2. To test this, p53 
was coexpressed together with the conjugating enzyme for Nedd8, hUbc12 and His-
tagged Nedd8 (later called Nedd8-CS). This led to the occurrence of a slower 
migrating p53 band, which corresponds to neddylated p53 (Figure 5.5, lane 6). 
Addition of Mdm2 to the system resulted in a visible increase in the neddylation of 
p53, as represented by the four slower migrating bands of p53 (Figure 5.5, lane 5). 
This Mdm2-dependent neddylation of p53 was completely abrogated by the 
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Tip60 inhibited the neddylation activity of Mdm2 towards itself (Figure 5.5, compare 
lanes 2 and 3).  
Next, we sought to investigate the role of p14arf in p53- and Mdm2-neddylation in 
comparison to Tip60. We therefore expressed p14arf together with p53 and the 
Nedd8-CS, with or without Mdm2. Coexpression of p14arf also decreased p53-
neddylation, but to a far lesser extent than Tip60 (Figure 5.6, compare lanes 4 + 7).   
Concluding, Tip60 and p14arf are capable of inhibiting the Mdm2-dependent 
conjugation of Nedd8 and Ubiquitin, respectively, in a specific manner. While p14arf 

























Figure 5.5 : Impact of Tip60 on Mdm2-mediated Neddylation of p53.  
Impact of Tip60 on Mdm2-mediated neddylation of p53. U2OS cells were transfected with different 
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Figure 5.6: Impact of Tip60 and p14arf on Mdm2-mediated Neddylation of p53.  
Comparison of Tip60 and p14arf in their effect on Mdm2-mediated neddylation of p53. U2OS cells 
were transfected with different combinations of the indicated plasmids and harvested 40 h post 
transfection. Thereafter, the cells were processed as described in Figure 5.5. 
 
5.3 Interaction of Tip60 and Mdm2 
5.3.1 Mapping of the Mdm2-Tip60 interaction by co-immunoprecipitation 
Mdm2 and Tip60 physically interact (Legube et al., 2002; Legube et al., 2004). Co-
immunoprecipiation of wildtype Tip60 and Mdm2 is shown in Figure 5.7. Reciprocal 
co-immunoprecipitation also revealed the complex (lanes 5-12), whereas 
precipitation with the control antibody (anti-SV40-large T-antigen) did not yield a 
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To narrow down the mechanism by that Tip60 inhibits neddylation, we performed 
mutational analysis and asked to what extent the following activities of Tip60 co-
segregate: Mdm2-binding, Mdm2-relocalization, and the inhibition of Mdm2-mediated 
neddylation. We used mutants of Tip60, harbouring deletions of the MYST domain 
and the smaller catalytic HAT domain within MYST (mutants constructed by Max 
Koeppel; described in his diploma thesis). Exon 5 was deleted separately to mimic a 
naturally occurring splice variant of Tip60, termed PLIP (Sheridan et al., 2001). 
Furthermore, STOP-codons were introduced to yield C-terminally truncated forms of 
Tip60 (Figure 5.8 A).  
As shown in Figure 5.8 B, the Tip60 mutants under study still associated with Mdm2. 
We conclude that the portion corresponding to residues 1-262 in Tip60 is sufficient to 
bind Mdm2. In seeming contrast to this, it was previously reported that a fragment 
consisting of residues 1-258 did not co-precipitate Mdm2 (Legube et al., 2002). 
However, the latter fragment accumulated to extremely high levels, raising the 
possibility that squelching precluded co-precipitation despite interaction. 
Nonetheless, it remains possible that more than one domain of Tip60 is capable of 
forming a complex with Mdm2. In any case, our further studies (below) together 
indicate that Tip60-Mdm2-interaction can be separated from functional interference 













Figure 5.7: Co-immunoprecipitation of Tip60 and Mdm2.  
U2OS cells were transfected with expression plasmids for HA-Tip60, Mdm2, and empty vector in the 
combinations indicated and harvested after 24 h. The cells were lysed and the proteins were 
immunoprecipitated with an anti-HA-tag antibody (HA.11), an Mdm2-antibody (2A10) and a control 
antibody against SV40 large T antigen (PAb419). The proteins were eluted in 6x Laemmli buffer and 
separated by SDS-PAGE followed by detection of the proteins by immunoblot.  
HA-Tip60
Mdm2 - - + + - - + + - - + +
- + - + - + - + - + - + 
















- - + +






1   2   3  4kDa
Results                                                                                                                       59                      
 






























Figure 5.8: Mapping of the Tip60-Mdm2 association by Co-immunoprecipitation 
(A) Overview of the different Tip60 deletion mutants. The figure shows the domain structure of Tip60 
and the amino acids at the boundaries that are still present in the mutants.  
(B) U2OS cells were transfected with different expression plasmids for Tip60 mutants together with 
Mdm2 in the indicated combinations, followed by co-immunoprecipitation with the anti-Mdm2 antibody 
(2A10). The samples were further processed as described in Figure 5.7. 
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5.3.2 The MYST domain of Tip60 is required for the inhibition of Mdm2-
mediated neddylation  
 
In order to map the domains on Tip60 that are required for the inhibition of 
neddylation, the Tip60 mutants were coexpressed with p53, Mdm2 and the Nedd8-
CS.  
In contrast to Tip60wt (Figure 5.9, lane 11) and Tip60dHAT (lane 13), Tip60dMYST 
was not capable of inhibiting the occurrence of slower-migrating forms of p53 (lane 
12). The mutant lacking the Exon 5 (PLIP) was still able to inhibit the neddylation of 
p53 (lane 14), albeit less efficiently than Tip60wt (lane 11). The C-terminally 
truncated Tip60-mutants also depended on the presence of the MYST domain in 
their inhibitory effect on neddylation. While the Tip60STOP390 mutant (lane 16) still 
reduced Mdm2-mediated neddylation to a substantial extent, the Tip60STOP263 
mutant (lane 15) did not. The influence of the Tip60 mutants on the neddylation of 
Mdm2 itself reflected the situation of p53-neddylation.  
 
Figure 5.9: Impact of the deletion of different Tip60 domains on its inhibition of Mdm2-mediated 
p53-neddylation  
U2OS cells were transfected with different combinations of the indicated plasmids. Forty hours post 
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5.4 Impact of Tip60 on the intracellular localization of Mdm2 and 
p53 
In order to study the underlying mechanisms for the stabilization of Mdm2 and p53 by 
Tip60 and the inhibition of neddylation, the intracellular localization of Tip60, Mdm2 
and p53 was examined by co-immunofluorescence experiments. 
 
5.4.1 Coexpression of Mdm2 and Tip60 leads to the occurrence of nuclear 
dots  
To study the intracellular localization of Mdm2 and Tip60, H1299 cells were 
transfected with expression plasmids for HA-Tip60 and EGFP-Mdm2 and a co-
immunofluorescence was performed. Due to the lack of suitable antibodies to Tip60, 
we had to use an overexpression system with tagged Tip60, to study the localization. 
While the sole expression of Mdm2 or Tip60 led to a diffuse nuclear staining pattern 
of the proteins (Figure 5.10 A, first two rows), the coexpression of both proteins 
resulted in the appearance of nuclear dot-like structures (Fig.5.10 A, third row). 
Therefore, Tip60 is capable of relocalizing Mdm2 to nuclear structures.  
 
5.4.2 The MYST domain of Tip60 but not the HAT domain is required for the 
relocalization of Mdm2  
To study the role of the different domains in the relocalization of Mdm2 by Tip60, we 
coexpressed the different Tip60 mutants with Mdm2 followed by co-
immunofluorescence (Figure 5.10 A, rows 4-8) 
To quantify the impact of different Tip60 domains on the colocalization with Mdm2, 
the cells were counted and divided into three groups: cells exhibiting a diffuse 
nuclear Mdm2 staining pattern, cells with an intermediate phenotype between even 
distribution and colocalization, and cells that show a colocalization of both proteins 
exclusively in the nuclear dots.  
As shown in Figure 5.10 B, only the Tip60 mutants lacking the MYST domain show a 
clear shift of their phenotype towards an even distribution in the nucleus, strongly 
suggesting a function of this domain in the mutual relocalization of both proteins. In 
addition, the C-terminally truncated form, which lacks only the last 121 aa yields a 
phenotype with an equal distribution between the diffuse and the dot-like staining  







































































































































































































































































Figure 5.10: Mapping of the Tip60 domains required for relocalization of Mdm2 into nuclear 
dots 
(A) Impact of the deletion of different Tip60 domains on the colocalization with EGFP-Mdm2. H1299 
cells were transfected with equal amounts of the indicated expression plasmids. After 24 h, the cells 
were fixed and stained with antibodies against the HA-tag and EGFP. Nuclei were visualized wih 4,6'-
Diamidino-2-phenylindole (DAPI).  
(B) Statistical analysis of the immunofluorescence results, obtained as in (A). 150 cells showing a 
green staining were evaluated by an observer who was unaware of the identity of the samples and 
divided into three groups; those with a clear colocalization of both proteins in nuclear dots (white 
columns), those with a diffuse nuclear staining pattern (black columns) and those with an intermediate 
phenotype (grey columns). The graph shows the percentage of cells with a particular staining pattern. 
The error bars show the standard deviation from three independent experiments. 
(C) Colocalization of p53 with Mdm2 and Tip60. U2OS cells were transfected with the indicated 
plasmids and a co-immunofluorecence was performed with the antibodies anti-EGFP and anti-p53 
(FL393) as described in (A) 
The experiments shown in panel (A) and (B) were performed by Max Koeppel during his Diploma 
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pattern. This suggests that the C-terminal region of Tip60 is needed for the 
relocalization of Mdm2, although it is not required for Mdm2 binding.  
  
5.4.3 p53 also colocalizes to Tip60-Mdm2 nuclear dots 
Since the intracellular localization of p53 is tightly linked to its activity, the next 
question was, whether the localization of p53 was also affected upon the 
coexpression of Tip60 and Mdm2. U2OS cells were transfected with expression 
plasmids encoding for Mdm2 and p53 and additionally Tip60. While the coexpression 
of Mdm2 and p53 yielded a diffuse nuclear staining pattern (Figure 5.10 C upper 
panel), the additional expression of Tip60 led, as with Mdm2 alone, to a relocalization 
of p53 and Mdm2 to nuclear dots (Figure 5.10 C, lower panel). This finding suggests 
that Tip60, Mdm2 and p53 may be found in one complex upon coexpression.  
 
5.4.4 Mdm2, Tip60 and p53 localize to PML oncogenic domains  
The occurrence of nuclear dots upon coexpression of Tip60, Mdm2 and p53 
prompted us to study the identity of these nuclear structures. The nucleus contains 
various proteins that are frequently associated with dot-like structures. Our primary 
suspects were the PML nuclear bodies, because it had been shown before that 
Mdm2 and also p53 associate with these structures that contain several proteins 
involved in tumor suppression and transcriptional regulation (reviewed in Dellaire and 
Bazett-Jones, 2004). Since PML nuclear bodies can be visualized by staining of the 
PML protein, we performed a costaining of PML and EGFP-Mdm2 or p53 in the 
presence of Tip60. As shown in Fig.5.11A, a part of the nuclear dots observed by 
staining of EGFP-Mdm2, colocalize with PML nuclear bodies. The same observation 
was made for p53 and PML (Figure 5.11 B). This finding implies that PML might play 
a role in the relocalization of Mdm2 and p53 by Tip60 and potentially in the activity of 
Tip60 towards Mdm2 and p53.  
 
5.4.5 Mdm2 and Tip60 still localize to nuclear dots in pml minus MEFs 
Our next question was, whether the PML protein as a major component of the PML 
nuclear bodies is actually required for the Tip60-mediated relocalization of Mdm2. 
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For this purpose, we used mouse embryonic fibroblasts (MEFs) that are derived from 
PML wildtype (pml+/+) and PML knockout (pml-/-) mice, where both alleles of pml had 
been deleted by recombination. This system allowed us to study the role of PML in 
the relocalization of Mdm2 by Tip60. The staining of Mdm2 and Tip60 in pml+/+ MEFs 
exhibited the same pattern as observed before in H1299 cells (Figure 5.11B). 
Strikingly, this pattern did not change in pml -/- MEFs (Figure 5.11C) . Tip60 was still 
found in nuclear dots together with Mdm2, indicating that the PML protein is not 







Figure 5.11: Colocalization of Mdm2, Tip60 and p53 with PML nuclear bodies 
(A) Tip60-EGFP-Mdm2 nuclear dots colocalize with PML nuclear bodies. U2OS cells were transfected 
with the indicated expression plasmids and fixed after 24 h with 4% PFA, followed by permeabilization 
and immunostaining of EGFP-Mdm2 and PML. Nuclei were visualized by DAPI staining.   
(B) Tip60, EGFP-Mdm2 and p53 colocalize with PML nucelar bodies. U2OS cells were transfected 
with the indicated expression plasmids and 24 h post transfection processed as described in (A), but 
stained with antibodies against p53 and PML.   
























































































Figure 5.12: Comparison of Tip60- Mdm2 colocalization in pml+/+ and pml-/-  MEFs. 
pml+/+ MEFs (A) and pml-/-  MEFs (B) were transfected with the indicated combinations of plasmids 
using Lipofectamine 2000 and 24 h post transfection the cells were fixed with 4% PFA followed by 
permeabilization and immunostaining with the indicated antibodies. The nuclei were visualized by 
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5.5 Impact of Tip60 on p53 transcriptional activity  
Intrigued by the findings that Tip60 is capable of stabilizing p53, at the same time 
inhibiting its Mdm2-mediated neddylation, we were interested in the effect of Tip60 
on the transcriptional activity of p53. 
 
5.5.1 Overexpression of Tip60 does not lead to transcriptional activation of 
p53  
To study the impact of ectopically expressed Tip60 on the transcriptional activity of 
p53, we first performed a luciferase assay. To this end, H1299 cells were transfected 
with a p53-responsive reporter plasmid, containing a portion of the mdm2-intron in 
front of the luciferase gene, and different combinatons of plasmids encoding p53, 
Mdm2, Myc-p14arf and HA-Tip60, followed by a luciferase assay (chapter 4.2.4).  
As expected, the expression of p53 led to a strong induction of luciferase activity 
(Figure 5.13). The coexpression of Tip60 or p14arf did not alter the p53-dependent 
luciferase activity, but the coexpression of p53 and Mdm2 resulted in a strong 
reduction of the luciferase activity. The simultaneous expression of p14arf led to 
partial rescue of p53-activity, which was expected, because p14arf disrupts the 
Mdm2-p53 complex. However, when Tip60 was expressed together with p53 and 
Mdm2 this did not result in a rescue of luciferase activity.  
Since the luciferase assay is based on the measurement of p53-mediated 
transactivation of promoters that are not integrated into the cellular chromatin but  
located in the reporter plasmid DNA, this assay exhibits limitations. To overcome this 
limitation, we chose the approach of the quantitative realtime PCR (qRT-PCR) to 
determine the impact of Tip60 on the transcriptional activity of p53 on the 
endogenous p21/CDKN1A promoter. To this end, expression plasmids, encoding for 
p53, Mdm2, p14arf and Tip60 were transfected in different combinations in H1299 
cells followed by RNA extraction, reverse transcription and analysis of p21-gene 
expression. As shown in Figure 5.14 A, the expression of p53 strongly stimulated the 
p21-mRNA synthesis. The coexpression of Mdm2 and p53 led, as expected, to a 
pronounced reduction of p53 activity on the endogenous p21 promoter (Figure 5.14 
A). This inhibition of p53-induced p21-expression by Mdm2 could be counteracted by 
p14arf, nearly restoring the original p53-activity. 










Figure 5.13: Comparison of Tip60 and p14arf in their impact on p53 transcriptional activity in a 
luciferase assay.  
H1299 cells were transfected with a p53-responsive reporter plasmid (encoding a firefly luciferase) 
and the indicated combinations of expression plasmids for p53, HA-Tip60, Mdm2 and Myc-p14arf. 
After 24 h, the cells were harvested in reporter lysis buffer and a luciferase assay was performed. The 
protein amount of the samples was measured by a Bradford assay and the values of the luciferase 
activity were corrected accordingly.  
 
The simultaneous expression of Tip60 however, did not lead to a rescue of p53-
activity, thereby confirming the results obtained in the luciferase assay. The 
expression of p14arf and Tip60, in the presence of p53 but absence of Mdm2, even 
slightly decreased the levels of p21-mRNA while no effect was observed in case of 
the sole expression of p14arf and Tip60.  
These findings suggest that Tip60 overexpression does not affect the activity of 
overexpressed p53, at least in the system tested here.  
Next, we sought to investigate the impact of overexpressed Tip60 on the activity of 
endogenous p53. To test this, U2OS cells were transfected with expression plasmids 
encoding for p14arf, Tip60 and p53. Subsequently, a qRT-PCR was performed as 
described in 4.3.17. While the expression of p14arf led to a two fold increase in the 
p21-mRNA levels, Tip60 expression even led to a slight decrease of p53-
transcriptional activity (Fig. 5.14B). p53 expression did not result in a strong increase 





































































































Figure 5.14: Impact of Tip60 on endogenous p21-mRNA levels 
(A) Impact of Tip60 on the activity of overexpressed p53 to transactivate the endogenous p21-
promoter. H1299 cells were transfected with the indicated combinantions of expression plasmids 
encoding for p53, Mdm2, HA-Tip60 and Myc-p14arf. After 24 h, the cells were harvested followed by a 
RNA extraction, reverse transcription and quantification of GAPDH-mRNA (control gene) and p21-
mRNA levels by qRT-PCR.  
(B) U2OS were transfected with the indicated expression plasmids and the cells were harvested 24 h 
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5.5.2 siRNA-mediated knockdown of HTATIP expression leads to slightly 
reduced p21-mRNA synthesis 
Since the overexpression of Tip60 most probably results in Tip60 protein levels that 
significantly exceed its physiological levels, we also sought to determine the effect of 
HTATIP-gene knockdown on the transcriptional activity of endogenous p53. To this 
end, U2OS cells were transfected with siRNA directed against HTATIP, TP53 and 
MDM2 followed by qRT-PCR analysis of the p21/CDKN1A gene.  
However, we were not capable of obtaining consistent results regarding the effect of 
HTATIP knockdown on p53 target gene expression whereas the knockdown of the 
TP53 gene readily reduced the p21-mRNA levels. The knockdown of MDM2 
expression led to a four fold increase of p21-mRNA levels, since the repression of 
p53 was releaved. Our results differed in four different experiments from an effect of 
about 25% reduction of p21-mRNA levels to about 55%. This was also dependent on 
the location the experiments were performed and the Real time PCR system used. 
However, the  HTATIP knockdown effiencies were very similar (about 10% remaining 
Tip60 mRNA levels; data not shown). Also, the effect of the siRNA targeting TP53 on 
the p21-mRNA levels was more or less comparable in both cases with 11% and 16% 
remaining p21 mRNA (first two experiments) and 12% and 36% (last two 
experiments).  
These results suggest that Tip60 is required only to a small extent for the p53-








































































Figure 5.15: Impact of siRNA-mediated HTATIP knockdown on endogenous p21-mRNA levels 
(A) U2OS cells were transfected with an control siRNA and siRNAs targeting HTATIP and TP53. After 
48 h, the cells were harvested followed by a RNA extraction, reverse transcription and quantification of 
GAPDH-mRNA (control gene) and p21-mRNA levels by qRT-PCR (Roche Lightcycler 2.0, Marburg).  
(B) U2OS cells were transfected with a control siRNA and siRNAs targeting HTATIP, TP53 and 
MDM2. After 48 h, the the cells were processed as described in (A), but run on the Real time PCR 
system 7300 (Applied Biosystems, Odense). The samples were loaded in triplicates on the 96well 
reaction plate. The error bars show the standard deviation from one experiment. 
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5.6 The role of Tip60 in UV-induced apoptosis 
Since we were not able to detect a consistent impairment of p53-dependent 
transcription after removal of Tip60 under non-stress conditions, we sought to 
investigate the role of Tip60 and p53 after UV-irradiation. It had been described 
previously that Tip60 plays a role in UV-induced apoptosis (Legube et al., 2002; 
Legube et al., 2004; Tyteca et al., 2006).  
 
5.6.1 siRNA-mediated knockdown of HTATIP expression results in inhibition 
of UV-induced apoptosis 
To study the effect of HTATIP knockdown on UV-induced apoptosis, U2OS cells 
were transfected with siRNA targeting the expression of HTATIP, MDM2, TP53BP1 
and TP53 followed by UV-irradiation 36 h post transfection. After 4 more hours, the 
cells were harvested and a Western Blot was performed. As shown in Figure 5.16, 
the knockdown of HTATIP in unirradiated cells did not result in an effect on PARP 
cleavage (lane 2). However, in cells that were UV-irradiated with 20J/m2 UV-C, 
HTATIP knockdown led to a reduction of PARP cleavage as indicated by less 
cleaved PARP (lower band; lane 7). Even at an UV radiation intensity of 80 J/m2, 
HTATIP knockdown impaired PARP cleavage. Surprisingly however, TP53 
knockdown did not lead to a decrease of PARP cleavage (lane, 4 hours after 
irradiation. siRNAs against TP53BP1 and MDM2 were used as positive controls. As a 
result of MDM2 knockdown, p21 protein accumulated, most likely leading to cell cycle 
arrest. Presumably, this is the reason for our observation that MDM2 knockdown 
inhibits the UV-induced apoptosis. TP53BP1 encodes for a well-known mediator of 
DNA damage that is required for a proper DNA damage response (reviewed in 
Adams and Carpenter, 2006) and its knockdown resulted in similar inhibition of 
PARP cleavage as HTATIP knockdown (lanes 10+15). Knockdown of HTATIP did 
not only impair the cleavage of PARP but also led to decreased gamma-H2AX 
protein levels after irradiation with 20 J/m2, but not after 80 J/ m2 (lane 7 and 12). This 
finding suggests that Tip60 is required in the immediate early response to UV 
irradiation as the accumulation of phosphorylated histone 2AX constitutes one of the 
first steps in the DNA damage response. Moreover, the short time after UV irradiation 
makes it unlikely that this effect is based on Tip60 influencing the transcriptional 
activation of apoptosis-related genes. As opposed to PARP cleavage and gamma-
H2AX-levels, HTATIP knockdown did not alter the expression of the p21-protein. 



















Figure 5.16: Impaired response to UV-irradiation upon removal of Tip60  
(A) U2OS-cells were transfected with control-siRNA (1) as well as siRNA against HTATIP (2), MDM2 
(3), TP53 (4) and TP53BP1 (5). After 24 hours, the cells were irradiated with UV-C light (20 J/m2). 
After 4 more hours of incubation, the cells were harvested, followed by immunoblot detection of PARP 
(cleavage by caspases and the concomitant occurrence of a band with higher electrophoretic mobility 
indicate apoptosis), gammaH2AX (phosphorylation of H2AX indicates DNA-damage response), as 
well as p53 and p21.   
 
 
5.6.2 siRNA-mediated knockdown of HTATIP expression results in decreased 
JNK-phosphorylation  
Given the fact that HTATIP knockdown leads to an early inhibition of UV-response in 
the cells, we were interested in the levels of the jun N-terminal kinase (JNK) that is 
one of the kinases, apart from ATR and ATM, which is activated immediately after 
DNA damage and also required for the phosphorylation of histone 2AX (Burma et al., 
2001; Lu et al., 2006; Ward et al., 2004). To study the impact of HTATIP knockdown 
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on JNK activation (measured by JNK phosphorylation) after UV irradiation, U2OS 
cells were treated either with siRNA against HTATIP and negative control siRNA. 
The protein expression was determined at different time points after irradiation by 
immunoblotting. As shown in Figure 5.17, phospho-JNK accumulation started 30 min 
after UV-C irradiation. HTATIP knockdown led to a reduction of JNK-phosphorylation 
already soon after exposure to UV light (lane 4), while the protein levels of total JNK 
remained unaltered. As observed before (Figure 5.16), the PARP cleavage was 
inhibited by HTATIP specific siRNA (lanes 9+10).  
This result stresses the role of Tip60 in the immediate early response to UV, 
establishing a role of Tip60 in another kinase pathway in addition to involvement in 













Figure 5.17: Impact of Tip60 knockdown on the phosphorylation of JNK 
U2OS were transfected with either control siRNA (1) or Tip60 siRNA (2). Twenty-four hours later, the 
cells were UV-irradiated (20 J/m2) as described in Fig.5.16.  Harvesting of the cells was performed at 
the indicated time points after UV-C-irradiation, followed by immunoblot detection of phosphorylated 
JNK, total JNK and PARP.  
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6.1 Differential regulation of the Mdm2 E3 ligase activity by Tip60 
 
The results presented in this work suggest that Tip60 can act as a specific inhibitor of 
Mdm2-mediated neddylation. This concept reconciles three previous findings:  
i) Tip60 turned out to represent an essential cofactor of p53, based on a genome-
wide siRNA screen (Berns et al., 2004); ii) Tip60 was found to interact with Mdm2 but 
failed to block Mdm2-mediated ubiquitination (Legube et al., 2004); and iii) Mdm2 can 
antagonize p53 not only by ubiquitination, but also by neddylation (Xirodimas et al., 
2004). In the light of these three previous notions, and based on the results shown 
here, we suggest that a plausible role of Tip60 in p53 regulation consists in an 
antagonism of Mdm2-mediated neddylation. In contrast, p14arf appears as the 
principal antagonist of ubiquitination by Mdm2.  
At first glance, it seems surprising that the two E3 ligase activities of Mdm2 can be 
differentially regulated. After all, both activities require the intact RING domain near 
the carboxyterminus of Mdm2, and the disruption of this structure by mutation of 
residue Cys 464 abolishes both of them (Xirodimas et al., 2004). Also, neddylation 
and ubiquitination affect an overlapping set of lysine residues within the 
carboxyterminal domain of p53 (Xirodimas et al., 2004). The exact mechanisms that 
nonetheless allow the selective regulation of each activity remain to be determined. 
However, a few possibilities can be addressed by the results shown here. For 
instance, a functional acetyl transferase domain of Tip60 is not required for 
antagonizing Mdm2-mediated neddylation, arguing that Tip60 does not interfere with 
neddylation by acetylating one of the involved components. The acetylation of Mdm2 
by CBP, for instance, had been shown to inhibit its ubiquitination activity towards p53 
(Wang et al., 2004). 
Further, by mutational analysis, the ability of Tip60 to bind Mdm2 could be separated 
from its ability to block neddylation.  
Our results indicated that all Tip60 mutants studied still interact with Mdm2. 
Therefore, we conclude that the portion corresponding to residues 1-262 in Tip60 is 
sufficient to bind Mdm2. In seeming contrast to this, it was previously reported that a 
fragment consisting of residues 1-258 did not co-precipitate Mdm2 (Legube et al., 
2004). However, the latter fragment accumulated to extremely high levels, raising the 
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possibility that squelching precluded co-precipitation despite interaction. 
Nonetheless, it remains possible that more than one domain of Tip60 is capable of 
forming a complex with Mdm2.  
We therefore speculate that Tip60 does not simply act by binding Mdm2 but might in 
addition interact with a third partner to inhibit the ligation of Nedd8. Such a partner 
could also mediate the relocalization of Tip60 and Mdm2 to nuclear bodies, since 
relocalization and blocked neddylation co-segregated in our mapping experiments on 
Tip60 (Table 1).  
 
 Association with Mdm2 in Co-IP 
Relocalisation of 
Mdm2 
Inhibition of  





Tip60 wild type + + + + + + + + + + + + 
Tip60dHAT + + + + + + + + + + + + 
Tip60dMYST + + - - - - - - - - - - 
Tip60dEXON5 + + + + + - + + - + + - 
Tip60STOP263 + + - - - - - - - - - - 
Tip60STOP390 + + + + - -  + + - + + - 
 
Table 1: Contribution of the Tip60 domains to the different effects of Tip60 on Mdm2 
 
The finding that Mdm2 stimulated p53-neddylation in vitro only very weakly in 
comparison to p53-ubiquitination which was readily induced by Mdm2 (Xirodimas et 
al., 2004), may also be interpreted as a hint towards an unknown factor that might be 
required for Mdm2-mediated neddylation to occur.  
The protein Cul4A, a member of the Cullin protein family, could represent a potential 
third factor, targeted by Tip60, that already was implicated in the Mdm2-mediated 
degradation of p53 by stimulating its polyubiquitination by Mdm2. Furthermore, Cul4A 
binds to Mdm2 (Nag et al., 2004). The inactivation of Cul4A leads to accumulation of 
p53 and its target gene p21 (Higa et al., 2006). As other Cullin proteins, Cul4A is 
neddylated and its neddylation is required for its proper activity. Although no 
cofactors have been described that are required for the Neddylation of p53 by Mdm2, 
Cul4A might be such a candidate. Tip60 might disrupt the binding of Cul4A to Mdm2, 
thereby interfering with its neddylation activity. Furthermore, recent work revealed a 
role of Cul4A in the DNA damage response, where it is engaged in a complex that 
ubiquitinates the histones H2A, H3 and H4 (Kapetanaki et al., 2006; Wang et al., 
2006), two of which already have been described to be substrates of Tip60 
acetylation (Ikura et al., 2000). However, the study of the Mdm2-mediated p53 
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neddylation in TS-41 cells that carry a temperature-sensitive neddylation pathway, 
show that the E3 ubiquitin ligase activity of Mdm2 is not regulated through 
neddylation of cullins (Xirodimas et al., 2004).  
Since p14arf and Tip60 not only affect different E3 ligase activities of Mdm2 but also 
relocalize Mdm2 to distinct intranuclear structures (nucleoli vs. nuclear bodies), it is 
conceivable that the differential relocalization at least contributes to differential E3 
ligase regulation. PML nuclear bodies have been reported to be sites of 
posttranslational modifications of proteins upon cellular stress like DNA damage but 
they have not been implicated yet in the regulation of protein-neddylation. The 
relocalisation of Mdm2 by p14arf to nucleoli has been described to play a role in the 
inhibition of Mdm2-activity. However, there are reports demonstrating that the 
relocalisation is not required for p53 stabilization (Llanos et al., 2001).  
The only known regulators of cellular neddylation so far are the ASPP2 (apoptosis 
stimulating protein of p53) protein which had been implicated in the inhibition of APP-
BP1 leading to decreased neddylation of cullins (Chen et al., 2003). Furthermore the 
enzyme Nedp1 and the COP9 signalosome regulate the levels of neddylated proteins 
by cleavage of Nedd8 (Mendoza et al., 2003; Min et al., 2005).  
At present, the exact biological purpose of two distinct E3 ligase activities on Mdm2 
and their separate regulation is unkown. Earlier reports have identified Tip60 as an 
essential cofactor for p53, showing that the knockdown of HTATIP by siRNA severely 
impairs the ability of p53 to transactivate its target genes (Berns et al., 2004; Legube 
et al., 2004). It is therefore tempting to speculate that a reduction in endogenous 
Tip60 levels might increase Mdm2- mediated neddylation of p53. In such a concept, 
increased p53 neddylation would then compromise transcriptional activity (Xirodimas 
et al., 2004). However, we were unable to observe such an effect directly . At least in 
the cells under study here, efficient knockdown of HTATIP gene expression (more 
than 80%) only led to a very moderate reduction in the expression of the p53 target 
gene p21 (typically less than 30%) (discussed in 6.1.3), and the stable 
overexpression of exogenous Tip60 was compatible with continued cell proliferation, 
even in U2OS cells that carry wildtype p53 (data not shown). We therefore propose 
that Tip60, and possibly its ability to block Mdm2-mediated p53 neddylation, may 
activate p53 only under specific circumstances or cell species that still await their 
identification.  
Nonetheless, our results do show that, in principle, two different Mdm2 E3 ligase 
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activities can be individually regulated, at least suggesting the evolution of tunable 
and independent mechanisms that differentially affect the stability and transcriptional 
activity of p53.  
In the other characterized system for Nedd8 conjugation, Rbx1, the RING finger 
component of the SCF complex, which is required for ubiquitin ligase activity, can 
also act as an E3 Nedd8 ligase for cullins (Gray et al., 2002; Kamura et al., 1999; 
Morimoto et al., 2003). However, unlike in the case of Mdm2, studies of Rbx1 
mutants suggest that some Rbx1 mutations preferably affect ubiquitylation, whereas 
others more affect neddylation (Megumi et al., 2005; Xirodimas et al., 2004).  
The differential regulation of Mdm2-mediated ubiquitination and neddylation by Tip60 
are in line with findings of Xirodimas et al. (2004), that p53 ubiquitination and 
neddylation are differentially regulated by UV-induced DNA damage. They 
demonstrated, by using stably-transfected MCF-7 cells (derived from carcinoma of 
the breast), that while the ubiquitinaton of p53 was inhibited 4 h post UV-irradiation 
and sustained 8 h post UV, p53 neddylation was transiently increased 4 h post UV 
but could not be detected by 8  h after UV irradiation. Taking this into account, UV 
irradiation would reduce Tip60 and p53 ubiquitination and thereby block their 
degradation, allowing Tip60 to inhibit additionally Mdm2-mediated Neddylation of 
p53, thereby further stimulating its transcriptional activity. An increase of Tip60 
protein after UV irradiation would then lead to an inhibition of p53-Neddylation. Tip60 
is probably only the first of several factors to be identified that can regulate the 
decision of ubiquitination versus neddylation.  
It is somewhat puzzling that Tip60 also inhibited Mdm2-autoneddylation, thereby 
depressing its antagonising activity towards p53. However, an analogous observation 
has been reported for p14arf, which blocks p53 ubiquitination but also Mdm2 
autoubiquitination. 
 
6.1.1 The role of PML and the PML nuclear bodies 
 
It is somewhat surprising to see that Tip60 and Mdm2 relocalize each other to 
nuclear bodies even in pm l-/- cells (Fig. 5.12). However, it should be noted that 
nuclear bodies have previously been observed in the absence of PML. An example is 
provided by the human homeodomain-interacting protein kinase (HIPK) 2. HIPK2 not 
only interacts with and phosphorylates p53 (D'Orazi et al., 2002; Hofmann et al., 
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2002) but also localizes to nuclear bodies. These HIPK2 nuclear bodies coincide, at 
least in part, with the pattern of PML localization, but they are observed even when 
PML is absent (Moller et al., 2003). Hence, nuclear bodies can form in the absence 
of PML. The identity of scaffold proteins that allow the accumulation of Mdm2 and 
Tip60 in nuclear bodies independently of PML is currently under investigation.  
It remains to be determined what role the PML protein plays in the inhibition of 
Mdm2-mediated neddylation of p53 by Tip60. Due to very low transfection 
efficiencies in the pml wild type and pml null MEFs, this issue could not be addressed 
in this work.  
PML and the PML nuclear bodies have been implicated as an important player in the 
regulation of p53 stability and activity. Inhibition of PML expression was reported to 
have no detectable effect on the expression of endogenous p53 at the mRNA level; 
but led to a significant decrease of p53 protein (Bao-Lei et al., 2006). Moreover, an 
increase in the p53-Mdm2 complexes was observed, which may facilitate p53 protein 
degradation by the ubiquitin-proteasome pathway, also in irradiation treated cells. 
Furthermore, it was reported that p53 transcriptional activity was attenuated both in 
unstressed and gamma-irradiated cells upon removal of PML. Also, inhibition of PML 
expression in MCF-7 cells significantly reduced the expression of p53 downstream 
genes like p21/CDKN1A and Bax (Bao-Lei et al., 2006).  
Mdm2, PML and p53 form temporal complexes in response to DNA damage (Kurki et 
al., 2003). Following UV irradiation, p53 forms a complex with PML, but only at a 
kinetically narrow window between 1-3 hours after the damage; Mdm2 complex 
formation with PML is also transient, peaking at 3 hours.  
Although, Legube et al. (2004) also found that Tip60 relocalizes Mdm2 and p53 to 
PML nuclear bodies, it cannot be ruled out that part of the nuclear dots observed are 
due to the high protein levels after transient transfection. The protein levels of Tip60 
and Mdm2 were usually very high in the transfected cells. As a consequence, Tip60 
and Mdm2 might accumulate to such high levels that insoluble protein aggregates 
form. Therefore, it would be conceivable that a part of these complexes actually 
contain chaperones and proteasomes, which associate with clusters of unfolded 
proteins. In fact, it has been shown that Mdm2 and p14arf accumulate in extra-
nucleolar bodies that are targeted by the PML protein and show an association with 
proteasomes and the stress protein HSP70 (Kashuba et al., 2003). There are also 
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hints that PML bodies are involved in the regulation of protein degradation of nuclear 
proteins. For instance, misfolded influenza nucleoprotein accumulates in PML 
nuclear bodies in cells where proteasome mediated degradation is inhibited 
suggesting that PML bodies function as the nuclear analogues of the cytoplasmic 
aggregosome (Anton et al., 1999). 
 
6.1.2 Mechanism of p53 and Mdm2 stabilization by Tip60 
 
Our results suggest that Tip60 does not interfere with the Mdm2-mediated 
ubiquitination of p53, but stabilizes it by inhibiting a subsequent step in the 
degradation process (Fig. 5.4). Mdm2 is required for both ubiquitination and 
degradation of p53. Consistent with our findings, Legube et al. (2004) reported that 
Tip60 overexpression results in the accumulation of ubiquitinated p53 forms in the 
presence of Mdm2.  
The finding that siRNA against HTATIP leads to a decrease of Mdm2 protein levels 
at the same time leaving the p53 levels unaltered, points to a stronger dependence of 
Mdm2 stability on Tip60 than p53. Legube et al. (2004) only found a very weak 
reduction in p53 protein levels upon knockdown of Tip60. This effect may also 
strongly depend on the cell line under study. 
Although the mechanism is not fully characterized, a post-ubiquitination role has 
been proposed for Mdm2 in the p53 degradation pathway (Brignone et al., 2004; 
Glockzin et al., 2003; Kulikov et al., 2005) (Figure 6.2 A). Also, it recently has been 
demonstrated that Mdm2 directly binds to the C8 subunit of the 20S proteasome and 
promotes Rb protein degradation in a proteasome-mediated manner (Sdek et al., 
2005). Therefore, Mdm2 may function as a post ubiquitination adaptor for its 
ubiquitinated substrates, with assistance of other proteasome-interacting proteins like 
the human homolog of Rad23 (hHR23) (Brignone et al., 2004; Glockzin et al., 2003). 
Other proteasome interacting proteins that deliver ubiquitinated substrates to the 19S 
regulator subunit of the 26S proteasome, potentially targeted by Tip60, are Dsk2 
(dominant suppressor of Kar2) and Ddi1 (DNA damage molecule 1) (reviewed in 
(Welchman et al., 2005). Thus, Tip60 could either directly interfere with the Mdm2-
proteasome interaction or manipulate the activity of proteasome-interacting proteins, 
explaining its ability to stabilize p53. 
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The small ribosomal protein L11 has recently been shown to inhibit Mdm2 
degradation by a postubiquitination mechanism (Dai et al., 2006), supporting this 
hypothesis.  
Given that Tip60 relocalizes Mdm2 and p53 to PML nuclear bodies (Figure 6.2 C), it 
is also conceivable that p53 and Mdm2 stabilization is in part due to an inhibition of 
nuclear export. Such a mechanism has already been described for p53 stabilisation 
by p14arf (Tao and Levine, 1999). 
Besides p53, it was recently shown that its homologue p73 (and specifically its 
isoforms containing an aminoterminal transactivation domain) can also be neddylated 
in an Mdm2-dependent manner (Watson et al., 2006). We therefore assume that 
Tip60 not only affects posttranslational modifications on p53 but also on p73 and 
possibly p63.  
Taken together, the results presented here strongly suggest that the Mdm2 
oncoprotein not only carries out two distinct E3 ligase activities but that these 
activities can also be regulated individually by different factors. In perspective, this 
suggests an unexpected versatility of Ubiquitin ligases. With hundreds of Ubiquitin 
conjugating enzmes of the E3 type expressed by the human genome (Ciechanover, 
2005), the targeting of Ubiquitin conjugation has already reached enormous 
complexity (Figure 6.1). If even a small fraction of these ligases turned out to carry 
out additional and individually regulated conjugation of several Ubiquitin-like 
modifiers, this would even further increase the flexibility of the system. Mdm2 may 
only represent the first example of such an E3 ligase that not only integrates multiple 
regulatory inputs but can also respond with individual combinations of at least two 
different output activities. 
 
6.1.3 Impact of Tip60 on the transcriptional activity of p53 
 
Given the fact that Tip60 has been described previously to play a role in the 
transcriptional activation of p53 target genes like p21/CDKN1A, revealed both by 
knockdown and overexpression experiments (Berns et al., 2004, Legube et al., 
2004), it is astonishing that the overexpression of Tip60 did not result in an increase 
of p53 activity measured both by luciferase assay and qRT-PCR analysis. In our 
experiments, the protein levels of p53 did not correlate with its transcriptional activity. 
Legube et al. (2004) have reported that Tip60, Mdm2 and p53 coprecipitated when 
overexpressed. 





Figure 6.1: Complexity of the ubiquitin cascade 
The ubiquitin cascade is pyramidal in design. A single E1-activating enzyme transfers ubiquitin to 
roughly three dozen E2s, which function together with several hundred different E3 ubiquitin ligases to 
ubiquitylate thousands of substrates. The differential regulation of different E3-ligase activities (e.g. 
ubiquitination versus neddylation) would add even another level to this complexity. Taken from Nalepa 
et al., 2006. 
 
Therefore, it is conceivable that p53 is stabilized by Tip60 but still is impaired in its 
transcriptional activation by Mdm2 binding to its N-terminal transactivation domain 
while p14arf sequesters Mdm2 away from p53, thereby stimulating the transcriptional 
activity of p53 (Tao and Levine, 1999; Weber et al., 1999).  Moreover, 
overexpression of proteins involved in transcription has been described to provoke so 
called squelching effects. In such a case, a transcription factor or coactivator binds in 
a saturating fashion to the binding sites of proteins involved in transcription, thereby 
disrupting the integrity of the complex in question. 
In fact, Tip60 has been described to repress the activity of a reporter plasmid 
responsive to the Fe65 protein (Scheinfeld et al., 2003). While the interaction domain 
of Mdm2 with p14arf is mapped (Weber et al., 2000), very little is known about the 
binding site of Tip60 on Mdm2 (Legube et al., 2002; Legube et al., 2004). Unlike 
Tip60, p14arf was capable of partially rescuing the transcriptional activity of p53 in 
luciferase assays as well as in qRT-PCR analysis.  
 
















Figure 6.2: The role of Tip60 in the p53 pathway 
(A) Tip60 inhibits the degradation of p53 and Mdm2, but not their ubiquitination, probably also under 
non-stress conditions. Therefore it most likely inhibits the degradation at a step between ubiquitination 
and degradation by the proteasome. (B) Tip60 colocalizes with Mdm2 and p53 to PML nuclear bodies, 
thereby potentially inhibiting their nuclear export. (C) Tip60 is involved in the transactivation of 
transcription by p53, possibly as a part of the HAT complex NuA4. (D) Tip60 inhibits the Mdm2-
mediated conjugation of Nedd8 to p53 and towards Mdm2 itself. Figure modified from Hoeller et al., 
2006. 
 
The fact that Tip60 does not inhibit the Mdm2-mediated ubiquitination of p53 (Figure 
5.4), but rather interferes with a subsequent step, is consistent with the finding that 
overexpression of Tip60 does not rescue p53 transcriptional activity. Ubiquitinated 
p53 might still be associated with Mdm2 and thereby kept inactive.  
Furthermore, our results stand in contrast to the findings of Berns et al., Legube et al. 
and Tyteca et al. that found a strong reduction in the p21-mRNA levels upon Tip60 
knockdown whereas our experiments only showed a light effect of Tip60 knockdown 
on p53 transcriptional activity in exactly the same cell line (U2OS). So far, we cannot 
explain this discrepancy. However, it is possible that the differences are at least in 
part due to slightly different experimental setups, and although the same cell line was 
used, certain genetic alterations in the cell lines, resulting in a different experimental 
outcome cannot be ruled out completely.  
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However, the sole knockdown of HTATIP expression by siRNA does not allow to 
draw conclusions on the mechanism of reduced p21-expression. Tip60 could act on 
multiple levels as discussed before, e.g. inhibition of Mdm2 neddylation, and also 
function as a p53 cofactor in transcription. To elucidate the mechanisms, it would be 
conceivable to perform rescue experiments where different siRNA-resistant Tip60-
mutants are reintroduced into the cell by transfection after knockdown of endogenous 
HTATIP expression, followed by analysis of gene expression. 
 
6.1.4 Tip60 and p14arf 
 
It remains to be determined, what roles Tip60 plays in the p14arf-p53 pathway. The 
impact of p14arf on Tip60 can be most probably neglected as U2OS cells, which 
were mainly used in these studies, do not contain the p14arf protein due to 
methylation of its gene promoter at the INK4A/ARF locus (Park et al., 2002).  
However, two recent reports highlighted new functional interactions between Tip60, 
p14arf and pRb, independently from p53. First, Tip60 was shown to bind and 
acetylate pRb, resulting in increased pRb degradation (Leduc et al., 2006). 
Overexpression of p14arf prevented pRb acetylation, hence stabilizing pRb. 
Furthermore it was shown that p14arf and Tip60 can form a complex in cells (Eymin 
et al., 2006). p14arf overexpression induced an ATM-ATR-dependent DNA damage 
response in p53-null cells, in a Tip60-dependent manner. Genotoxic stress led to 
p14arf dependent accumulation of pRb, as well as Arf- and Tip60-dependent 
activation of ATM. Thus, ARF appears to antagonize Tip60 in terms of pRb 
degradation, whereas the two proteins work together in the DNA damage response 
and p53 phosphorylation.  
 
6.2 The role of Tip60 in the UV-induced apoptosis 
 
Tip60 was recently identified as an essential cofactor in UV-mediated apoptosis 
(Tyteca et al., 2006), and consistent with this, we found that UV-mediated cleavage 
of poly ADP ribose polymerase (PARP), a substrate of caspases, was attenuated 
when Tip60 was removed by siRNA prior to irradiation (Fig. 5.16 and 5.17). 
Strikingly, we observed that the removal of p53 did not confer such protection against 
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apoptosis in a parallel experiment, arguing that the knockdown of HTATIP does not 
exert its effect through attenuating the p53 response.  
Furthermore, studies in the Drosophila eye revealed that p53 knockdown increases 
the UV sensitivity (Jassim et al., 2003). 
Even more surprisingly, however, it turned out that the removal of Tip60 not only 
interfered with caspase activation, but also with the phosphorylation of histone 2AX 
(measured by the accumulation of γ-H2AX). This argues that Tip60 is required for the 
early response triggered by UV-induced genotoxicity. H2AX phosphorylation has long 
been known to be induced by the classical signalling kinases ATM/Chk2 and 
ATR/Chk1, the latter being particularly implied in the UV response.  
Also, Tip60 and histone 2AX have previously been shown to be linked, e.g. by the 
finding that the Tip60 homologue in drosophila is required fo the exchange of 
phosphorylated H2Av, the homolog of mammalian H2AZ isoform (which is not 
phosphorylated by ATM) but contains the same PIKK-target (phosphatidylinositol 3-
kinase-related kinase) residue as H2AX (Ser 139 in both cases). Here, the 
acetylation of H2Av by the Tip60 complex initiates its exchange, performed probably 
by another member of the Tip60 complex, the p400 protein (Kusch et al., 2004). 
In our hands, HTATIP knockdown not only led to a reduction of H2AX-
phosphorylation upon UV irradiation, but also reduced the phosphorylation of the jun-
terminal kinase JNK at a very early timepoint (30 min post UV irradiation). It was 
found more recently that H2AX phosphorylation in response to UV light requires the 
induction of JNK (Lu et al., 2006), perhaps as a result of daxx (death domain 
associated protein) relocalization. Daxx is found associated with the PML NBs where 
also Tip60 has been found (Khelifi et al., 2005). Recent reports suggest that UV 
irradiation induces the ubiquitination and degradation of Daxx, releasing its 
interaction partner RASSF1C (Ras association domain family 1C) from the nucleus 
(Kitagawa et al., 2006). This in turn leads to the activation of the SAPK/JNK (stress 
activated kinase/ jun-N-terminal kinase) pathway. It is conceivable that Tip60 is 
needed for the ubiquitination and degradation of Daxx, maybe by acetylating it. The 
lack of Tip60 would then result in a block of Daxx degradation and retention of 
RASSF1C in the nucleus. Furthermore, Daxx has been reported to play a critical role 
in regulating Mdm2 by stabilizing it and stimulating its ubiquitination towards p53 
(Tang et al., 2006). 
Discussion                                                                                                                  86 
 
In summary, Tip60 can favor p53 activity through several independent and possibly 
additive mechanisms.  In this work, two additional roles of Tip60 have been unveiled 
that potentially contribute to tumor suppression. First, Tip60 can inhibit the Mdm2-
mediated conjugation of the Nedd8 protein to p53, thereby possibly releaving it from 
transcriptional inhibition by Mdm2. Moreover, Tip60 apparently is required for the 
proper activation of the UV-induced JNK-signaling pathway, thereby ensuring an 
efficient response to DNA damage and apoptosis induction. 
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8 APPENDIX 
8.1 Modification of Tip60 by Ubiquitin-like proteins   
The regulation of protein activity is mainly accomplished on the level of 
posttranslational modifications. In this work, the impact of Tip60 on p53 and Mdm2 
posttranslational modifications was investigated. We were now interested, whether 
Tip60 itself is modified by Ubiquitin-like proteins like Nedd8 or SUMO-1. 
So far, the only described posttranslational modifications of Tip60 represent its 
phosphorylation by the Cyclin b/cdc2 kinase (Lemercier et al., 2003), its 
ubiquitination by Mdm2 (Legube et al., 2002) and its acetylation by the histone acetyl 
transferase p300 (Col et al., 2005).  
 
8.1.1 Tip60 is modified by Nedd8 
Since Mdm2 is capable of acting as an E3 ligase for Nedd8 and we further observed 
an inhibition of Mdm2-mediated neddylation of p53 by Tip60 (chapter 5.2.2), we 
asked whether Tip60 might be modified by Nedd8. To test, whether Tip60 is 
neddylated, Tip60 was coexpressed with His-tagged Nedd8 and hUbc12 followed by 
a Nickel-His-tag Pulldown. As shown in Figure 8.1, the coexpression of His-12-
Nedd8 resulted in the appearance of bands with lower electrophorectic mobility, 
corresponding to neddylated Tip60 forms (lane 2). Upon additional coexpression of 
hUbc12, a further accumulation of slower migrating Tip60 bands was observed, 
which confirms the identity of neddylated Tip60 (lane 4). These findings suggest that 
Tip60 is modified by Nedd8. As Nedd8 is not able to form chains like ubiquitin 
(reviewed in Hoeller et al., 2006), the appearance of several slower migrating bands 
points to the modification of multiple lysines in Tip60.  
 
8.1.2 Impact of Mdm2 on Tip60 neddylation 
Next, we wanted to investigate whether Mdm2 had an impact on the neddylation of 
Tip60. To this end, Mdm2 was overexpressed together with Tip60 and the Nedd-CS. 
As shown in Figure 8.2, Mdm2 coexpression did not stimulate neddylation of Tip60 
but rather led to a decrease in neddylated Tip60 and unmodified Tip60 (compare 
lanes 3+4). Since Mdm2-mediated ubiquitination of Tip60 targets it for degradation, it 
is likely that the decrease of neddylated Tip60 is due to a decrease of total Tip60 
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levels. This finding suggests that not every substrate of Mdm2 ubiquitination is at the 
same time subject to neddylation by Mdm2. It remains to be determined if Mdm2 
catalyzes the neddylation of further substrates apart from p53 and itself. 
 
8.1.3 Mapping of neddylation sites on Tip60 
Next, we were interested, which domains on Tip60 were targeted by neddylation. So 
far, no general consensus motif for neddylation, apart from one for cullins, has been 
described (Pan et al., 2004). Therefore, we overexpressed different Tip60 deletion 
mutants together with the Nedd8-conjugating system and performed a His-tag-
Pulldown. However, no change of the neddylation pattern was observed upon 
deletion of Exon 5 , the MYST domain or the complete C-terminus from amino acid 
390 onwards (Figure 8.3). This suggests that Tip60 is most probably modified in its 














Figure 8.1: Neddylation of Tip60.                         
U2OS cells were transfected with the indicated combinations of the expression plasmids for His-
tagged Nedd8, hUbc12, Tip60 and Mdm2. The cells were harvested 36 h post transfection and were 
lysed in His-tag-Pulldown lysis buffer folllowed by the His-tag Pulldown procedure. The proteins were 
separated by SDS-PAGE and detected by immunoblotting.  
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Figure 8.2: Impact of Mdm2 on Tip60 neddylation                       
U2OS cells were transfected with the indicated combinations of the expression plasmids for His-
tagged Nedd8, hUbc12, Tip60 and Mdm2. The cells were harvested 36 h post transfection, lysed in 
His-tag-Pulldown lysis buffer folllowed by the His-tag pulldown procedure. The proteins were 
separated by SDS-PAGE and detected by immunoblotting.  
 
The potential function of Tip60 neddylation remains to be determined. It is 
conceivable that the neddylation of Tip60 regulates the association with other 
proteins as Mdm2 or binding partners in the NuA4-Tip60 complex.  
 
8.1.4 Tip60 is modified by SUMO-1 
Given the fact, that Tip60, Mdm2 and p53 colocalise with PML nuclear bodies that 
have been described to be sites of protein modification with the Ubiquitin-like modifier 
SUMO-1, we were interested whether Tip60 could be modified with SUMO-1. As 
Nedd8, SUMO-1 belongs to the family of Ubiquitin-like proteins. It exhibits a 
sequence identity of 20% to Ubiquitin and has been implicated in several cellular 
pathways like DNA damage repair and maintenance of genomic intergrity (reviewed 
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Figure 8.3: Neddylation of Tip60 mutants.                                                 
U2OS cells were transfected with the indicated combinations of the expression plasmids for His-
tagged Nedd8, hUbc12, Tip60. The cells were harvested 36 h post transfection and were lysed in His-
tag-Pulldown lysis buffer folllowed by the His-tag Pulldown procedure. 
 
Its conjugation to proteins requires the E1 activating enzyme SAE1/SAE2 and the E2 
conjugating enzyme Ubc9. E3 ligases for SUMO-1 have also been decribed.  
Furthermore, a search for SUMOylation consensus sites using the SUMOplot site in 
the internet (http://www.abgent.com/doc/sumoplot), revealed several potential 
sumoylation sites in Tip60. A SUMOylation consensus site consists of the following 
amino acids: ψ-K-x-D/E (where lysine is the modified amino acid, ψ is a hydrophobic 
residue and x is any amino acid residue) To test this, Tip60 was coexpressed with 
His-tagged SUMO-1 in U2OS cells followed by a Nickel-His-tag pulldown. As shown 
in Figure 8.5, the coexpression of Tip60 with SUMO-1 led to the occurrence of slower 
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Tip60 Isoform 2 
 
    1   MAEVGEIIEG CRLPVLRRNQ DNEDEWPLAE ILSVKDISGR KLFYVHYIDF  
   51   NKRLDEWVTH ERLDLKKIQF PKKEAKTPTK NGLPGSRPGS PEREVPASAQ  
  101   ASGKTLPIPV QITLRFNLPK EREAIPGGEP DQPLSSSSCL QPNHRSTKRK  
  151   VEVVSPATPV PSETAPASVF PQNGAARRAV AAQPGRKRKS NCLGTDEDSQ  
  201   DSSDGIPSAP RMTGSLVSDR SHDDIVTRMK NIECIELGRH RLKPWYFSPY  
  251   PQELTTLPVL YLCEFCLKYG RSLKCLQRHL TKCDLRHPPG NEIYRKGTIS  
  301   FFEIDGRKNK SYSQNLCLLA KCFLDHKTLY YDTDPFLFYV MTEYDCKGFH  
  351   IVGYFSKEKE STEDYNVACI LTLPPYQRRG YGKLLIEFSY ELSKVEGKTG  
  401   TPEKPLSDLG LLSYRSYWSQ TILEILMGLK SESGERPQIT INEISEITSI  
  451   KKEDVISTLQ YLNLINYYKG QYILTLSEDI VDGHERAMLK RLLRIDSKCL  
  501   HFTPKDWSKR GKW 
 
Figure 8.4: Potential SUMOylation consensus sites in Tip60 as obtained with SUMOplot™ 
(www.abgent.com) 
Amino acid sequence of Tip60. Consensus sites with a low probability are marked in blue, those with a 
high probability in red. 
 
8.1.5 Mapping of SUMOylation sites on Tip60 
Next, we wanted to investigate whether the deletion of certain Tip60 domains would 
abolish the appearance of SUMOylated Tip60 forms. For this purpose, different Tip60 
deletion mutants were coexpressed with His-12-SUMO-1 in U2OS cells followed by a 
Nickel-His-tag-pulldown. 
All Tip60 deletion mutants tested are still modified with SUMO-1 as seen in Figure 
8.5. Also the mutation of two SUMOylation consensus sites in Tip60 did not result in 
decreased SUMOylation of Tip60 (data not shown). Therefore it remains to be 
determined which lysine residues of Tip60 are modified by Tip60. Furthermore, it is 
unclear whether the SUMOylation of Tip60 actually occurs under physiological 
conditions and which role it has. Since PML NBs have been shown to be sites of 
increased SUMO-1 modification, it would be conceivable that the relocalization of 
Tip60 to the PML NBs is required for this modification to occur. Again, it could play a 
role in regulating the activity of the Tip60 protein, or its association of other proteins 
of the Tip60 complex. Previous reports point to a rather inhibitory role of 
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Figure 8.5: SUMOylation of Tip60 mutants in U2OS cells.                       
U2OS cells were transfected with expression plasmids for His-tagged SUMO-1, and Tip60 as well as 
different Tip60 deletion mutants. The cells were harvested 36 h post transfection and were lysed in 
His-tag-Pulldown lysis buffer folllowed by the His-tag Pulldown procedure (Chapter 4.2.5), SDS-PAGE 
and immunoblot analysis. Asteriks indicate bands that correspond to SUMOylated Tip60 forms.  
 
8.2 The Impact of Tip60 on the localization of Mdm2-analogues 
Since we found that expression of Tip60 together with Mdm2 led to a redistribution of 
both proteins to nuclear dot-like structures (5.4.4) and given the fact that Tip60 had 
been found to colocalize also with hPirh2 (Logan et al., 2004), a Mdm2-analogue, we 
asked whether Tip60 could colocalize with another Mdm2 analog, called COP1. 
COP1 (constitutive photomorphogenetic 1) was only recently identified as an E3-
Ubiquitin-Ligase for p53 (Dornan et al., 2004). It is the human homolog of a plant 
protein that is required for the proper regulation of photomorphogenesis (Deng et al., 
1991).  
8.2.1 The Mdm2-analogue COP1 colocalizes with Tip60 to PML nuclear bodies    
To study the effect of Tip60 on COP1 localization, EGFP-COP1 was expressed 


























































































































































































































































Appendix                                                                                                                  101 
 
was performed. As shown in Figure 8.6, COP1 and Tip60 exhibit a colocalization in 
nuclear dots and also in clusters in the cytoplasm (panel B) whereas COP1 alone 
does not localize to nuclear dots (panel A). However, the colocalization is not so 
clear as in the case of Mdm2 and Tip60. The intracellular localization of COP1 had 
previously been shown be both cytoplasmic and nuclear (Bianchi et al., 2003; Yi et 
al., 2002). Nevertheless, this finding hints to a potential physical association of Tip60 
and COP1.  
Next, we were interested in whether the nuclear dots formed by Tip60 and COP1 
would also colocalize with PML nuclear bodies as in the case of Mdm2 and Tip60. To 
test this, we coexpressed HA-Tip60 and EGFP-COP1 and performed a co-
immunofluorescence where the cells were stained with an antibody against PML and 
EGFP-COP1. Indeed, the dots formed by Tip60 and COP1 colocalized very strongly 
with the PML nuclear bodies as seen in Figure 8.6 C, thereby establishing a parallel 
to the situation with Mdm2 and Tip60. In fact, this is the first hint that COP1 localizes 
to PML nuclear bodies, despite the observation that plant COP1 and mammalian 
PML exhibit a similar intracellular localization (Reyes, 2001). 
In conclusion, these results suggest that Tip60 does not only associate and regulate 
Mdm2 but that it also potentially acts on its analogue COP1. Taken together, Tip60 
might regulate p53 abundance and activity by interfering with the three most 
important p53 antagonists: Mdm2, hPirh2 and COP1.  
It remains to be elucidated whether Tip60 actually directly interacts with COP1 and 
whether it inhibits its activity towards p53. However, the fact that Tip60 
overexpression leads to an increase in p53 levels (Chapter 5.1.1) does not exclude 
an effect of Tip60 on COP1 activity apart from inhibiting Mdm2. A role of Tip60 in the 
inhibition of postubiquitination step could also accommodate the inhibition of COP1-
dependent p53 degradation. Recently it was reported that COP1 is phosphorylated 
by ATM, leading to its degradation (Dornan et al., 2006). Since Tip60 acetylation of 
ATM is required for its activation, it could make sense that Tip60 also directly 
interferes with COP1. However, this remains to be determined.  
Taken together, the data presented in this appendix point to many functions of Tip60 
that still await their identification.  
 
 











Figure 8.6 Impact of Tip60 on the intracellular localization of COP1.                                        
(A) U2OS cells were transfected with an expression plasmid for EGFP-COP1. After 24 h, the cells 
were fixed with 4% PFA, permabilized with triton X-100 and stained with the indicated antibodies. 
Nuclei were visualized by DAPI staining. 
(B) U2OS cells were transfected with expression plasmids for and HA-Tip60 and EGFP-COP1, fixed 
with 4% PFA and further processed as in (A). 
(C) U2OS cells were transfected with expression plasmids for and HA-Tip60 and EGFP-COP1, fixed 
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c                      concentration 
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